Terapia y Tratamiento

Embed Size (px)

Citation preview

  • 8/20/2019 Terapia y Tratamiento

    1/134

    Chapter 16

    Therapy and Treatment

    Figure 16.1 >KV CLOJP LC QEBO>MV E>SB BBK ABSBILMBA QL QOB>Q > TFAB >OO>V LC MOLIBJP. EBPB J>OFKBP TEL

    PBOSBA FK O>N >KA !CDE>KFPQ>K, QLDBQEBO TFQE @LJJRKFQV JBKQ>I EB>IQE SLIRKQBBOP, >OB M>OQ LC QEB @B>K EBO>MV

    MOLDO>J >Q #>JM BKAIBQLK, > MOLDO>J FK TEF@E IB>OKFKD QL PROC FP @LJFKBA TFQE DOLRM AFP@RPPFLKP. EB MOLDO>J

    EBIMP SBQP OB@LSBO, BPMB@F>IIV SBQP TEL PRCCBO COLJ MLPQ-QO>RJ>QF@ PQOBPP AFPLOABO ().

    Chapter Outline

    16.1 BKQ>I B>IQE OB>QJBKQ: >PQ >KA OBPBKQ

    16.2 VMBP LC OB>QJBKQ

    16.3 OB>QJBKQ LA>IFQFBP

    16.4 RPQ>K@B-BI>QBA >KA !AAF@QFSB FPLOABOP: ! MB@F>I #>PB

    16.5 EB L@FL@RIQRO>I LABI >KA EBO>MV QFIFW>QFLK

    Introduction

    E>Q @LJBP QL JFKA TEBK VLR QEFKH >LRQ QEBO>MV CLO MPV@ELILDF@>I MOLIBJP? LR JFDEQ MF@QROBPLJBLKB IVFKD LK > @LR@E Q>IHFKD >LRQ EFP @EFIAELLA TEFIB QEB QEBO>MFPQ PFQP >KA Q>HBP KLQBP, \ I>

    FDJRKA OBRA. RQ @>K VLR BKSFPFLK > QEBO>MV PBPPFLK FK TEF@E PLJBLKB FP TB>OFKD SFOQR>I OB>IFQVEB>ADB>O QL @LKNRBO > CB>O LC PK>HBP?

    K QEFP @E>MQBO, VLR TFII PBB QE>Q >MMOL>@EBP QL QEBO>MV FK@IRAB LQE MPV@ELILDF@>I >KA FLILDF@>IFKQBOSBKQFLKP, >II TFQE QEB DL>I LC >IIBSF>QFKD AFPQOBPP. B@>RPB MPV@ELILDF@>I MOLIBJP @>K LOFDFK>QBCOLJ S>OFLRP PLRO@BPoFLILDV, DBKBQF@P, @EFIAELLA BUMBOFBK@BP, @LKAFQFLKFKD, >KA PL@FL@RIQRO>IFKCIRBK@BPoMPV@ELILDFPQP E>SB ABSBILMBA J>KV AFCCBOBKQ QEBO>MBRQF@ QB@EKFNRBP >KA >MMOL>@EBP. LOBU>JMIB, PLJB MPV@ELILDFPQP BIFBSB QE>Q MPV@ELQEBO>MV PELRIA FKSLISB > @ILPB MBOPLK>I OBI>QFLKPEFM BQTBBK QEBO>MFPQ >KA @IFBKQ, TEFIB LQEBOP BIFBSB QEBFO J>FK OBPMLKPFFIFQV FP QL EBIM QEB M>QFBKQ @E>KDB

    #E>MQBO 16 EBO>MV >KA OB>QJBKQ 609

  • 8/20/2019 Terapia y Tratamiento

    2/134

     BE>SFLO. EB @B>K EBO>MV MOLDO>J PELTK FK Figure 16.1 RPBP JRIQFMIB >MMOL>@EBP QL PRMMLOQ QEBJBKQ>I EB>IQE LC SBQBO>KP FK QEB DOLRM.

    16.1 Mental Health Treatment: Past and Present

    Learning Objectives

    V QEB BKA LC QEFP PB@QFLK, VLR TFII B >IB QL:k   UMI>FK ELT MBLMIB TFQE MPV@ELILDF@>I AFPLOABOP E>SB BBK QOB>QBA QEOLRDELRQ QEB >DBPk   FP@RPP ABFKPQFQRQFLK>IFW>QFLKk   FP@RPP QEB T>VP FK TEF@E JBKQ>I EB>IQE PBOSF@BP >OB ABIFSBOBA QLA>Vk   FPQFKDRFPE BQTBBK SLIRKQ>OV >KA FKSLIRKQ>OV QOB>QJBKQ

    BCLOB TB BUMILOB QEB S>OFLRP >MMOL>@EBP QL QEBO>MV RPBA QLA>V, IBQsP BDFK LRO PQRAV LC QEBO>MV VILLHFKD >Q ELT J>KV MBLMIB BUMBOFBK@B JBKQ>I FIIKBPP >KA ELT J>KV OB@BFSB QOB>QJBKQ. @@LOAFKD QLQEB .. BM>OQJBKQ LC B>IQE >KA RJ>K BOSF@BP (2013), 19% LC .. >ARIQP BUMBOFBK@BA JBKQ>I FIIKBPPFK 2012. LO QBBKP (>DBP 13n18), QEB O>QB FP PFJFI>O QL QE>Q LC >ARIQP, >KA CLO @EFIAOBK >DBP 8n15, @ROOBKQBPQFJ>QBP PRDDBPQ QE>Q 13% BUMBOFBK@B JBKQ>I FIIKBPP FK > DFSBK VB>O (>QFLK>I KPQFQRQB LC BKQ>I B>IQE

    )FQE J>KV AFCCBOBKQ QOB>QJBKQ LMQFLKP >S>FI>IB, >MMOLUFJ>QBIV ELT J>KV MBLMIB OB@BFSB JBKQ>I EB>IQEQOB>QJBKQ MBO VB>O? @@LOAFKD QL QEB RPQ>K@B RPB >KA BKQ>I B>IQE BOSF@BP AJFKFPQO>QFLK(), FK 2008, 13.4% LC >ARIQP OB@BFSBA QOB>QJBKQ CLO > JBKQ>I EB>IQE FPPRB (, K.A.-). EBPBMBO@BKQ>DBP, PELTK FK Figure 16.2, OBCIB@Q QEB KRJBO LC >ARIQP TEL OB@BFSBA @>OB FK FKM>QFBKQ >KALRQM>QFBKQ PBQQFKDP >KA/LO RPBA MOBP@OFMQFLK JBAF@>QFLK CLO MPV@ELILDF@>I AFPLOABOP.

    Figure 16.2 EB MBO@BKQ>DB LC >ARIQP TEL OB@BFSBA JBKQ>I EB>IQE QOB>QJBKQ FK 2004e2008 FP PELTK. !ARIQP PBBHFKD

    QOB>QJBKQ FK@OB>PBA PIFDEQIV COLJ 2004 QL 2008.

    EFIAOBK >KA >ALIBP@BKQP >IPL OB@BFSB JBKQ>I EB>IQE PBOSF@BP. EB BKQBOP CLO FPB>PB LKQOLI >KAOBSBKQFLK'P >QFLK>I B>IQE >KA RQOFQFLK U>JFK>QFLK ROSBV () CLRKA QE>Q >MMOLUFJ>QBIVE>IC (50.6%) LC @EFIAOBK TFQE JBKQ>I AFPLOABOP E>A OB@BFSBA QOB>QJBKQ CLO QEBFO AFPLOABO TFQEFK QEB M>PQVB>O (, K.A.-@). LTBSBO, QEBOB TBOB PLJB AFCCBOBK@BP BQTBBK QOB>QJBKQ O>QBP V @>QBDLOV LC 

    610 #E>MQBO 16 EBO>MV >KA OB>QJBKQ

    EFP @LKQBKQ FP >S>FI>IB CLO COBB >Q https://cnx.org/content/col11629/1.5

  • 8/20/2019 Terapia y Tratamiento

    3/134

    AFPLOABO (Figure 16.3). LO BU>JMIB, @EFIAOBK TFQE >KUFBQV AFPLOABOP TBOB IB>PQ IFHBIV QL E>SB OB@BFSBAQOB>QJBKQ FK QEB M>PQ VB>O, TEFIB @EFIAOBK TFQE LO > @LKAR@Q AFPLOABO TBOB JLOB IFHBIV QL OB@BFSBQOB>QJBKQ. >K VLR QEFKH LC PLJB MLPPFIB OB>PLKP CLO QEBPB AFCCBOBK@BP FK OB@BFSFKD QOB>QJBKQ?

    Figure 16.3 !LRQ LKB-QEFOA QL LKB-E>IC LC .. >ALIBP@BKQP (>DBP 8e15) TFQE JBKQ>I AFPLOABOP OB@BFSB QOB>QJBKQ,

     TFQE BE>SFLO-OBI>QBA AFPLOABOP JLOB IFHBIV QL B QOB>QBA.

    LKPFABOFKD QEB J>KV CLOJP LC QOB>QJBKQ CLO JBKQ>I EB>IQE AFPLOABOP >S>FI>IB QLA>V, ELT AFA QEBPB CLOJPLC QOB>QJBKQ BJBODB? BQsP Q>HB > ILLH >Q QEB EFPQLOV LC JBKQ>I EB>IQE QOB>QJBKQ COLJ QEB M>PQ (TFQE PLJBNRBPQFLK>IB >MMOL>@EBP FK IFDEQ LC JLABOK RKABOPQ>KAFKD LC JBKQ>I FIIKBPP) QL TEBOB TB >OB QLA>V.

    TREATMENT IN THE PAST

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sP LAV, >KA PEB J>V E>SB BBK DFSBK PLJB JBAF@FK>IAOFKHP. KLQEBO CLOJ LC QOB>QJBKQ CLO BUQOBJB @>PBP LC JBKQ>I FIIKBPP T>P QOBMEFKFKD: PJ>II ELIB T>PJ>AB FK QEB >CCIF@QBA FKAFSFAR>IsP PHRII QL OBIB>PB PMFOFQP COLJ QEB LAV. LPQ MBLMIB QOB>QBA FK QEFP J>KKBOAFBA. K >AAFQFLK QL BULO@FPJ >KA QOBMEFKFKD, LQEBO MO>@QF@BP FKSLISBA BUB@RQFLK LO FJMOFPLKJBKQ LC MBLMIB TFQE MPV@ELILDF@>I AFPLOABOP. QFII LQEBOP TBOB IBCQ QL B ELJBIBPP BDD>OP. BKBO>IIV PMB>HFKD,JLPQ MBLMIB TEL BUEFFQBA PQO>KDB BE>SFLOP TBOB DOB>QIV JFPRKABOPQLLA >KA QOB>QBA @ORBIIV. EB

    MOBS>FIFKD QEBLOV LC MPV@ELM>QELILDV FK B>OIFBO EFPQLOV T>P QEB FAB> QE>Q JBKQ>I FIIKBPP T>P QEB OBPRIQ LC ABJLKF@ MLPPBPPFLK V BFQEBO >K BSFI PMFOFQ LO >K BSFI DLA B@>RPB B>OIV BIFBCP FK@LOOB@QIV >QQOFRQBA >IIRKBUMI>FK>IB MEBKLJBK> QL ABFQFBP ABBJBA BFQEBO DLLA LO BSFI.

    OLJ QEB I>QB 1400P QL QEB I>QB 1600P, > @LJJLK BIFBC MBOMBQR>QBA V PLJB OBIFDFLRP LOD>KFW>QFLKP T>PQE>Q PLJB MBLMIB J>AB M>@QP TFQE QEB ABSFI >KA @LJJFQQBA ELOOFIB >@QP, PR@E >P B>QFKD >FBP (IRJBOD,2007). EBPB MBLMIB TBOB @LKPFABOBA QL B TFQ@EBP >KA TBOB QOFBA >KA @LKABJKBA V @LROQPoQEBV TBOBLCQBK ROKBA >Q QEB PQ>HB. LOIATFAB, FQ FP BPQFJ>QBA QE>Q QBKP LC QELRP>KAP LC JBKQ>IIV FII MBLMIB TBOBHFIIBA >CQBO BFKD >@@RPBA LC BFKD TFQ@EBP LO RKABO QEB FKCIRBK@B LC TFQ@E@O>CQ (BJMEFII, 1966)

    #E>MQBO 16 EBO>MV >KA OB>QJBKQ 611

  • 8/20/2019 Terapia y Tratamiento

    4/134

    V QEB 18QE @BKQROV, MBLMIB TEL TBOB @LKPFABOBA LAA >KA RKRPR>I TBOB MI>@BA FK >PVIRJP ( Figure 16.4).Asylums TBOB QEB CFOPQ FKPQFQRQFLKP @OB>QBA CLO QEB PMB@FCF@ MROMLPB LC ELRPFKD MBLMIB TFQE MPV@ELILDF@>IAFPLOABOP, RQ QEB CL@RP T>P LPQO>@FWFKD QEBJ COLJ PL@FBQV O>QEBO QE>K QOB>QFKD QEBFO AFPLOABOP. CQBK QEBPBMBLMIB TBOB HBMQ FK TFKALTIBPP ARKDBLKP, B>QBK, @E>FKBA QL QEBFO BAP, >KA E>A IFQQIB QL KL @LKQ>@Q TFQE@>OBDFSBOP.

    Figure 16.4 EFP M>FKQFKD V O>K@FP@L LV>, @>IIBA The Madhouse, ABMF@QP > JBKQ>I >PVIRJ >KA FQP FKE>FQ>KQP FK

    QEB B>OIV 1800P. Q MLOQO>VP QELPB TFQE MPV@ELILDF@>I AFPLOABOP >P SF@QFJP.

    K QEB I>QB 1700P, > OBK@E MEVPF@F>K, EFIFMMB FKBI, >ODRBA CLO JLOB ERJ>KB QOB>QJBKQ LC QEB JBKQ>IIV FII.B PRDDBPQBA QE>Q QEBV B RK@E>FKBA >KA Q>IHBA QL, >KA QE>QsP GRPQ TE>Q EB AFA CLO M>QFBKQP >Q > >IMdQOFcOBFK >OFP FK 1795 (Figure 16.5). >QFBKQP BKBCFQBA COLJ QEFP JLOB ERJ>KB QOB>QJBKQ, >KA J>KV TBOB >IBQL IB>SB QEB ELPMFQ>I.

    Figure 16.5 EFP M>FKQFKD V LKV LBOQ-IBROV ABMF@QP O. EFIFMMB FKBI LOABOFKD QEB OBJLS>I LC @E>FKP COLJ

    M>QFBKQP >Q QEB >IM\QOFZOB >PVIRJ FK >OFP.

    K QEB 19QE @BKQROV, LOLQEB> FU IBA OBCLOJ BCCLOQP CLO JBKQ>I EB>IQE @>OB FK QEB KFQBA Q>QBP (Figure16.6). EB FKSBPQFD>QBA ELT QELPB TEL >OB JBKQ>IIV FII >KA MLLO TBOB @>OBA CLO, >KA PEB AFP@LSBOBA >KRKABOCRKABA >KA RKOBDRI>QBA PVPQBJ QE>Q MBOMBQR>QBA >RPB LC QEFP MLMRI>QFLK (FCC>KV, 1891). LOOFCFBA V EBO CFKAFKDP, FU BD>K ILVFKD S>OFLRP PQ>QB IBDFPI>QROBP >KA QEB .. LKDOBPP CLO @E>KDB (FCC>KV,1891). BO BCCLOQP IBA QL QEB @OB>QFLK LC QEB CFOPQ JBKQ>I >PVIRJP FK QEB KFQBA Q>QBP.

    612 #E>MQBO 16 EBO>MV >KA OB>QJBKQ

    EFP @LKQBKQ FP >S>FI>IB CLO COBB >Q https://cnx.org/content/col11629/1.5

  • 8/20/2019 Terapia y Tratamiento

    5/134

    Figure 16.6 LOLQEB> FU T>P > PL@F>I OBCLOJBO TEL B@>JB >K >ASL@>QB CLO QEB FKAFDBKQ FKP>KB >KA T>P

    FKPQORJBKQ>I FK @OB>QFKD QEB CFOPQ !JBOF@>K JBKQ>I >PVIRJ. EB AFA QEFP V OBIBKQIBPPIV ILVFKD PQ>QB IBDFPI>QROBP >KA

    #LKDOBPP QL PBQ RM >KA CRKA PR@E FKPQFQRQFLKP.

    BPMFQB OBCLOJBOPs BCCLOQP, ELTBSBO, > QVMF@>I >PVIRJ T>P CFIQEV, LCCBOBA SBOV IFQQIB QOB>QJBKQ, >KA LCQBKHBMQ MBLMIB CLO AB@>ABP. Q FII>OA PV@EF>QOF@ BKQBO FK RMPQ>QB BT LOH, CLO BU>JMIB, LKB QOB>QJBKQ

    T>P QL PRJBODB M>QFBKQP FK @LIA >QEP CLO ILKD MBOFLAP LC QFJB. IB@QOLPEL@H QOB>QJBKQ T>P >IPL RPBA,>KA QEB T>V QEB QOB>QJBKQ T>P >AJFKFPQBOBA LCQBK OLHB M>QFBKQPs >@HP; FK 1943, AL@QLOP >Q FII>OA>AJFKFPQBOBA 1,443 PEL@H QOB>QJBKQP (FII>OA PV@EF>QOF@ BKQBO, 2009). (IB@QOLPEL@H FP KLT @>IIBABIB@QOL@LKSRIPFSB QOB>QJBKQ, >KA QEB QEBO>MV FP PQFII RPBA, RQ TFQE P>CBDR>OAP >KA RKABO >KBPQEBPF>.  OFBC >MMIF@>QFLK LC BIB@QOF@ PQFJRIRP FP RPBA QL MOLAR@B > DBKBO>IFWBA PBFWROB. LKQOLSBOPV @LKQFKRBP LSBOFQP BCCB@QFSBKBPP SBOPRP QEB PFAB BCCB@QP.) >KV LC QEB T>OAP >KA OLLJP TBOB PL @LIA QE>Q > DI>PP LC T>QBOTLRIA B COLWBK V JLOKFKD (FII>OA PV@EF>QOF@ BKQBO, 2009). FII>OAsP ALLOP TBOB KLQ @ILPBA RKQFI 1995.LKAFQFLKP IFHB QEBPB OBJ>FKBA @LJJLKMI>@B RKQFI TBII FKQL QEB 20QE @BKQROV.

    Q>OQFKD FK 1954 >KA D>FKFKD MLMRI>OFQV FK QEB 1960P, >KQFMPV@ELQF@ JBAF@>QFLKP TBOB FKQOLAR@BA. EBPBMOLSBA > QOBJBKALRP EBIM FK @LKQOLIIFKD QEB PVJMQLJP LC @BOQ>FK MPV@ELILDF@>I AFPLOABOP, PR@E >PMPV@ELPFP. PV@ELPFP T>P > @LJJLK AF>DKLPFP LC FKAFSFAR>IP FK JBKQ>I ELPMFQ>IP, >KA FQ T>P LCQBK

    BSFABK@BA V PVJMQLJP IFHB E>IIR@FK>QFLKP >KA ABIRPFLKP, FKAF@>QFKD > ILPP LC @LKQ>@Q TFQE OB>IFQV. EBKFK 1963, LKDOBPP M>PPBA >KA *LEK . BKKBAV PFDKBA QEB BKQ>I BQ>OA>QFLK >@FIFQFBP >KA LJJRKFQVBKQ>I B>IQE BKQBOP LKPQOR@QFLK @Q, TEF@E MOLSFABA CBABO>I PRMMLOQ >KA CRKAFKD CLO @LJJRKFQVJBKQ>I EB>IQE @BKQBOP (>QFLK>I KPQFQRQBP LC B>IQE, 2013). EFP IBDFPI>QFLK @E>KDBA ELT JBKQ>I EB>IQEPBOSF@BP TBOB ABIFSBOBA FK QEB KFQBA Q>QBP. Q PQ>OQBA QEB MOL@BPP LC  deinstitutionalization, QEB @ILPFKD LC I>ODB >PVIRJP, V MOLSFAFKD CLO MBLMIB QL PQ>V FK QEBFO @LJJRKFQFBP >KA B QOB>QBA IL@>IIV. K 1955, QEBOBTBOB 558,239 PBSBOBIV JBKQ>IIV FII M>QFBKQP FKPQFQRQFLK>IFWBA >Q MRIF@ ELPMFQ>IP (LOOBV, 1997). V 1994, VMBO@BKQ>DB LC QEB MLMRI>QFLK, QEBOB TBOB 92% CBTBO ELPMFQ>IFWBA FKAFSFAR>IP (LOOBV, 1997).

    MENTAL HEALTH TREATMENT TODAY

    LA>V, QEBOB >OB @LJJRKFQV JBKQ>I EB>IQE @BKQBOP >@OLPP QEB K>QFLK. EBV >OB IL@>QBA FK KBFDELOELLAPKB>O QEB ELJBP LC @IFBKQP, >KA QEBV MOLSFAB I>ODB KRJBOP LC MBLMIB TFQE JBKQ>I EB>IQE PBOSF@BP LC S>OFLRPHFKAP >KA CLO J>KV HFKAP LC MOLIBJP. KCLOQRK>QBIV, M>OQ LC TE>Q L@@ROOBA TFQE ABFKPQFQRQFLK>IFW>QFLKT>P QE>Q QELPB OBIB>PBA COLJ FKPQFQRQFLKP TBOB PRMMLPBA QL DL QL KBTIV @OB>QBA @BKQBOP, RQ QEB PVPQBJT>P KLQ PBQ RM BCCB@QFSBIV. BKQBOP TBOB RKABOCRKABA, PQ>CC T>P KLQ QO>FKBA QL E>KAIB PBSBOB FIIKBPPBP PR@E>P P@EFWLMEOBKF>, QEBOB T>P EFDE PQ>CC ROKLRQ, >KA KL MOLSFPFLK T>P J>AB CLO QEB LQEBO PBOSF@BP MBLMIBKBBABA, PR@E >P ELRPFKD, CLLA, >KA GL QO>FKFKD. FQELRQ QEBPB PRMMLOQP, QELPB MBLMIB OBIB>PBA RKABOABFKPQFQRQFLK>IFW>QFLK LCQBK BKABA RM ELJBIBPP. SBK QLA>V, > I>ODB MLOQFLK LC QEB ELJBIBPP MLMRI>QFLK FP@LKPFABOBA QL B JBKQ>IIV FII (Figure 16.7). Q>QFPQF@P PELT QE>Q 26% LC ELJBIBPP >ARIQP IFSFKD FK PEBIQBOPBUMBOFBK@B JBKQ>I FIIKBPP (.. BM>OQJBKQ LC LRPFKD >KA O>K BSBILMJBKQ MQBO 16 EBO>MV >KA OB>QJBKQ 613

  • 8/20/2019 Terapia y Tratamiento

    6/134

    Figure 16.7 (>) C QEB ELJBIBPP FKAFSFAR>IP FK .. PEBIQBOP, >LRQ LKB-NR>OQBO E>SB > PBSBOB JBKQ>I FIIKBPP (,

    2011). () #LOOB@QFLK>I FKPQFQRQFLKP >IPL OBMLOQ > EFDE KRJBO LC FKAFSFAR>IP IFSFKD TFQE JBKQ>I FIIKBPP. (@OBAFQ >:

    JLAFCF@>QFLK LC TLOH V #... OBV; @OBAFQ : JLAFCF@>QFLK LC TLOH V >OQ SBOPLK)

    KLQEBO DOLRM LC QEB JBKQ>IIV FII MLMRI>QFLK FP FKSLISBA FK QEB @LOOB@QFLKP PVPQBJ. @@LOAFKD QL >

    2006 PMB@F>I OBMLOQ V QEB ROB>R LC *RPQF@B Q>QFPQF@P (*), >MMOLUFJ>QBIV 705,600 JBKQ>IIV FII >ARIQPTBOB FK@>O@BO>QBA FK QEB PQ>QB MOFPLK PVPQBJ, >KA >KLQEBO 78,800 TBOB FK@>O@BO>QBA FK QEB CBABO>I MOFPLKPVPQBJ. CROQEBO 479,000 TBOB FK IL@>I G>FIP. @@LOAFKD QL QEB PQRAV, pMBLMIB TFQE JBKQ>I FIIKBPPBP >OBLSBOOBMOBPBKQBA FK MOL>QFLK >KA M>OLIB MLMRI>QFLKP >Q BPQFJ>QBA O>QBP O>KDFKD COLJ QTL QL CLRO QFJBPQEB DBKBO>I MLMRI>QFLKq (OFKP & O>MBO, 2009, M. 23). EB OB>QJBKQ ASL@>@V BKQBO OBMLOQBA QE>Q QEBDOLTFKD KRJBO LC JBKQ>IIV FII FKJ>QBP E>P MI>@BA > ROABK LK QEB @LOOB@QFLK>I PVPQBJ (LOOBV BQ >I.,2014).

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

    FBT QEFP timeline (http://openstaxcollege.org/l/timeline) PELTFKD QEB EFPQLOV LC

    JBKQ>I FKPQFQRQFLKP FK QEB KFQBA Q>QBP.

    LPQ MBLMIB PRCCBOFKD COLJ JBKQ>I FIIKBPPBP >OB KLQ ELPMFQ>IFWBA. C PLJBLKB FP CBBIFKD SBOV ABMOBPPBA,@LJMI>FKP LC EB>OFKD SLF@BP, LO CBBIP >KUFLRP >II QEB QFJB, EB LO PEB JFDEQ PBBH MPV@ELILDF@>I QOB>QJBKQ. COFBKA, PMLRPB, LO M>OBKQ JFDEQ OBCBO PLJBLKB CLO QOB>QJBKQ. EB FKAFSFAR>I JFDEQ DL PBB EFP MOFJ>OV @>OBMEVPF@F>K CFOPQ >KA QEBK B OBCBOOBA QL > JBKQ>I EB>IQE MO>@QFQFLKBO.

    LJB MBLMIB PBBH QOB>QJBKQ B@>RPB QEBV >OB FKSLISBA TFQE QEB PQ>QBsP @EFIA MOLQB@QFSB PBOSF@BPoQE>Q FP,QEBFO @EFIAOBK E>SB BBK OBJLSBA COLJ QEBFO @>OB ARB QL >RPB LO KBDIB@Q. EB M>OBKQP JFDEQ B OBCBOOBAQL MPV@EF>QOF@ LO PRPQ>K@B >RPB C>@FIFQFBP >KA QEB @EFIAOBK TLRIA IFHBIV OB@BFSB QOB>QJBKQ CLO QO>RJ>. C QEB M>OBKQP >OB FKQBOBPQBA FK >KA @>M>IB LC B@LJFKD BQQBO M>OBKQP, QEB DL>I LC QOB>QJBKQ JFDEQ B C>JFIV

    LINK TO LEARNING

    614 #E>MQBO 16 EBO>MV >KA OB>QJBKQ

    EFP @LKQBKQ FP >S>FI>IB CLO COBB >Q https://cnx.org/content/col11629/1.5

    http://openstaxcollege.org/l/timelinehttp://openstaxcollege.org/l/timeline

  • 8/20/2019 Terapia y Tratamiento

    7/134

    OBRKFCF@>QFLK. LO LQEBO @EFIAOBK TELPB M>OBKQP >OB RK>IB QL @E>KDBoCLO BU>JMIB, QEB M>OBKQ LO M>OBKQPTEL >OB EB>SFIV >AAF@QBA QL AORDP >KA OBCRPB QL BKQBO QOB>QJBKQoQEB DL>I LC QEBO>MV JFDEQ B QL EBIM QEB@EFIAOBK >AGRPQ QL CLPQBO @>OB >KA/LO >ALMQFLK (Figure 16.8).

    Figure 16.8 EBO>MV TFQE @EFIAOBK J>V FKSLISB MI>V. (@OBAFQ: iFW>OFB=!+j/IF@H4)

    LJB MBLMIB PBBH QEBO>MV B@>RPB QEB @OFJFK>I GRPQF@B PVPQBJ OBCBOOBA QEBJ LO OBNRFOBA QEBJ QL DL. LOPLJB FKAFSFAR>IP, CLO BU>JMIB, >QQBKAFKD TBBHIV @LRKPBIFKD PBPPFLKP JFDEQ B > @LKAFQFLK LC M>OLIB. C >K FKAFSFAR>I FP J>KA>QBA QL >QQBKA QEBO>MV, PEB FP PBBHFKD PBOSF@BP FKSLIRKQ>OFIV.  Involuntary treatmentOBCBOP QL QEBO>MV QE>Q FP KLQ QEB FKAFSFAR>IsP @ELF@B. QEBO FKAFSFAR>IP JFDEQ SLIRKQ>OFIV PBBH QOB>QJBKQ.Voluntary treatment JB>KP QEB MBOPLK @ELLPBP QL >QQBKA QEBO>MV QL LQ>FK OBIFBC COLJ PVJMQLJP.

    PV@ELILDF@>I QOB>QJBKQ @>K L@@RO FK > S>OFBQV LC MI>@BP. K FKAFSFAR>I JFDEQ DL QL > @LJJRKFQV JBKQ>IEB>IQE @BKQBO LO > MO>@QFQFLKBO FK MOFS>QB LO @LJJRKFQV MO>@QF@B. @EFIA JFDEQ PBB > P@ELLI @LRKPBILO,P@ELLI MPV@ELILDFPQ, LO P@ELLI PL@F>I TLOHBO. K FK@>O@BO>QBA MBOPLK JFDEQ OB@BFSB DOLRM QEBO>MV FKMOFPLK. EBOB >OB J>KV AFCCBOBKQ QVMBP LC QOB>QJBKQ MOLSFABOP, >KA IF@BKPFKD OBNRFOBJBKQP S>OV COLJ PQ>QBQL PQ>QB. BPFABP MPV@ELILDFPQP >KA MPV@EF>QOFPQP, QEBOB >OB @IFKF@>I PL@F>I TLOHBOP, J>OOF>DB >KA C>JFIVQEBO>MFPQP, >KA QO>FKBA OBIFDFLRP MBOPLKKBI TEL >IPL MBOCLOJ @LRKPBIFKD >KA QEBO>MV.

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

    >KA RJ>K BOSF@BP, 2005; >DBKCBIA, ROO>V, LE>QQ, & BORFVK, 1994). Q QEB BKA LC 2013, QEB ..BM>OQJBKQ LC DOF@RIQROB >KKLRK@BA >K FKSBPQJBKQ LC $50 JFIIFLK QL EBIM FJMOLSB >@@BPP >KA QOB>QJBKQCLO JBKQ>I EB>IQE MOLIBJP >P M>OQ LC QEB >J> >AJFKFPQO>QFLKsP BCCLOQ QL PQOBKDQEBK ORO>I @LJJRKFQFBP.

    #E>MQBO 16 EBO>MV >KA OB>QJBKQ 615

  • 8/20/2019 Terapia y Tratamiento

    8/134

    16.2 Types of Treatment

    Learning Objectives

    V QEB BKA LC QEFP PB@QFLK, VLR TFII B >IB QL:k   FPQFKDRFPE BQTBBK MPV@ELQEBO>MV >KA FLJBAF@>I QEBO>MVk   B@LDKFWB S>OFLRP LOFBKQ>QFLKP QL MPV@ELQEBO>MVk   FP@RPP MPV@ELQOLMF@ JBAF@>QFLKP >KA OB@LDKFWB TEF@E JBAF@>QFLKP >OB RPBA QL QOB>Q

    PMB@FCF@ MPV@ELILDF@>I AFPLOABOP

    KB LC QEB DL>IP LC QEBO>MV FP QL EBIM > MBOPLK PQLM OBMB>QFKD >KA OBBK>@QFKD ABPQOR@QFSB M>QQBOKP >KA QLPQ>OQ ILLHFKD CLO BQQBO PLIRQFLKP QL AFCCF@RIQ PFQR>QFLKP. EFP DL>I FP OBCIB@QBA FK QEB CLIILTFKD MLBJ:

     Autobiography in Five Short Chapters V LOQF> BIPLK (1993)

    E>MQBO KB T>IH ALTK QEB PQOBBQ.EBOB FP > ABBM ELIB FK QEB PFABT>IH. C>II FK.

    >J ILPQ. . . . >J EBIMIBPP.Q FPK'Q JV C>RIQ.Q Q>HBP CLOBSBO QL CFKA > T>V LRQ.

    E>MQBO TL T>IH ALTK QEB P>JB PQOBBQ.EBOB FP > ABBM ELIB FK QEB PFABT>IH. MOBQBKA ALK'Q PBB FQ. C>II FK >D>FK. @>K'Q BIFBSB >J FK QEFP P>JB MI>@B.RQ, FQ FPK'Q JV C>RIQ.Q PQFII Q>HBP > ILKD QFJB QL DBQ LRQ.

    E>MQBO EOBB T>IH ALTK QEB P>JB PQOBBQ.EBOB FP > ABBM ELIB FK QEB PFABT>IH. see FQ FP QEBOB. PQFII C>II FK . . . FQ'P > E>FQ . . . RQ,JV BVBP >OB LMBK. HKLT TEBOB >J.Q FP my C>RIQ. DBQ LRQ FJJBAF>QBIV.

    E>MQBO LRO T>IH ALTK QEB P>JB PQOBBQ.

    EBOB FP > ABBM ELIB FK QEB PFABT>IH. T>IH >OLRKA FQ.

    E>MQBO FSB T>IH ALTK >KLQEBO PQOBBQ.

    TL QVMBP LC QEBO>MV >OB MPV@ELQEBO>MV >KA FLJBAF@>I QEBO>MV. LQE QVMBP LC QOB>QJBKQ EBIM MBLMIB TFQEMPV@ELILDF@>I AFPLOABOP, PR@E >P ABMOBPPFLK, >KUFBQV, >KA P@EFWLMEOBKF>. Psychotherapy FP > MPV@ELILDF@>IQOB>QJBKQ QE>Q BJMILVP S>OFLRP JBQELAP QL EBIM PLJBLKB LSBO@LJB MBOPLK>I MOLIBJP, LO QL >QQ>FKMBOPLK>I DOLTQE. K JLABOK MO>@QF@B, FQ E>P BSLISBA FKL TE>Q FP HKLTK >P MPV@ELAVK>JF@ QEBO>MV,TEF@E TFII B AFP@RPPBA I>QBO.  Biomedical therapy  FKSLISBP JBAF@>QFLK >KA/LO JBAF@>I MOL@BAROBP QL

    616 #E>MQBO 16 EBO>MV >KA OB>QJBKQ

    EFP @LKQBKQ FP >S>FI>IB CLO COBB >Q https://cnx.org/content/col11629/1.5

  • 8/20/2019 Terapia y Tratamiento

    9/134

    QOB>Q MPV@ELILDF@>I AFPLOABOP. FOPQ, TB TFII BUMILOB QEB S>OFLRP MPV@ELQEBO>MBRQF@ LOFBKQ>QFLKP LRQIFKBA FKTable 16.1 (J>KV LC QEBPB LOFBKQ>QFLKP TBOB AFP@RPPBA FK QEB KQOLAR@QFLK @E>MQBO).

    Table 16.1 Various Psychotherapy Techniques

    Type Description Example

    PV@ELAVK>JF@MPV@ELQEBO>MV >IH QEBO>MV >PBA LK BIFBC QE>Q QEBRK@LKP@FLRP >KA @EFIAELLA @LKCIF@QPFJM>@Q BE>SFLO

    >QFBKQ Q>IHP >LRQ EFP M>PQ

    I>V QEBO>MV PV@EL>K>IVQF@>I QEBO>MV TEBOBFKFKQBO>@QFLK TFQE QLVP FP RPBA FKPQB>A LC Q>IH; RPBA FK @EFIA QEBO>MV

    >QFBKQ (@EFIA) >@QP LRQ C>JFIV P@BKBPTFQE ALIIP

    BE>SFLOQEBO>MV

    OFK@FMIBP LC IB>OKFKD >MMIFBA QL @E>KDBRKABPFO>IB BE>SFLOP

    >QFBKQ IB>OKP QL LSBO@LJB CB>O LC BIBS>QLOP QEOLRDE PBSBO>I PQ>DBP LC OBI>U>QFLK QB@EKFNRBP

    LDKFQFSBQEBO>MV T>OBKBPP LC @LDKFQFSB MOL@BPP EBIMPM>QFBKQP BIFJFK>QB QELRDEQ M>QQBOKP QE>QIB>A QL AFPQOBPP

    >QFBKQ IB>OKP KLQ QL LSBODBKBO>IFWBC>FIROB >PBA LK PFKDIB C>FIROB

    LDKFQFSB- BE>SFLO>IQEBO>MV

    LOH QL @E>KDB @LDKFQFSB AFPQLOQFLKP >KAPBIC-ABCB>QFKD BE>SFLOP

    >QFBKQ IB>OKP QL FABKQFCV PBIC-ABCB>QFKD BE>SFLOP QL LSBO@LJB >KB>QFKD AFPLOABO

    RJ>KFPQF@QEBO>MV

    K@OB>PB PBIC->T>OBKBPP >KA >@@BMQ>K@BQEOLRDE CL@RP LK @LKP@FLRP QELRDEQP

    >QFBKQ IB>OKP QL >OQF@RI>QB QELRDEQPQE>Q HBBM EBO COLJ >@EFBSFKD EBODL>IP

    PSYCHOTHERAPY TECHNIQUES: PSYCHOANALYSIS

    PV@EL>K>IVPFP T>P ABSBILMBA V FDJRKA OBRA >KA T>P QEB CFOPQ CLOJ LC MPV@ELQEBO>MV. Q T>PQEB ALJFK>KQ QEBO>MBRQF@ QB@EKFNRB FK QEB B>OIV 20QE @BKQROV, RQ FQ E>P PFK@B T>KBA PFDKFCF@>KQIV FKMLMRI>OFQV. OBRA BIFBSBA JLPQ LC LRO MPV@ELILDF@>I MOLIBJP >OB QEB OBPRIQ LC OBMOBPPBA FJMRIPBP>KA QO>RJ> BUMBOFBK@BA FK @EFIAELLA, >KA EB BIFBSBA MPV@EL>K>IVPFP TLRIA EBIM RK@LSBO ILKD-ROFBACBBIFKDP. K > MPV@EL>K>IVPQsP LCCF@B, VLR JFDEQ PBB > M>QFBKQ IVFKD LK > @LR@E PMB>HFKD LC AOB>JP LO@EFIAELLA JBJLOFBP, >KA QEB QEBO>MFPQ RPFKD S>OFLRP OBRAF>K JBQELAP PR@E >P COBB >PPL@F>QFLK >KA AOB>J>K>IVPFP (Figure 16.9). K free association, QEB M>QFBKQ OBI>UBP >KA QEBK P>VP TE>QBSBO @LJBP QL JFKA >Q QEBJLJBKQ. LTBSBO, OBRA CBIQ QE>Q QEB BDL TLRIA >Q QFJBP QOV QL IL@H, LO OBMOBPP, RK>@@BMQ>IB RODBP LOM>FKCRI @LKCIF@QP AROFKD COBB >PPL@F>QFLK. LKPBNRBKQIV, > M>QFBKQ TLRIA ABJLKPQO>QB OBPFPQ>K@B QL OB@>IIFKDQEBPB QELRDEQP LO PFQR>QFLKP. K dream analysis, > QEBO>MFPQ FKQBOMOBQP QEB RKABOIVFKD JB>KFKD LC AOB>JP.

    PV@EL>K>IVPFP FP > QEBO>MV >MMOL>@E QE>Q QVMF@>IIV Q>HBP VB>OP. SBO QEB @LROPB LC QFJB, QEB M>QFBKQOBSB>IP > DOB>Q AB>I >LRQ EFJPBIC QL QEB QEBO>MFPQ. OBRA PRDDBPQBA QE>Q AROFKD QEFP M>QFBKQ-QEBO>MFPQOBI>QFLKPEFM, QEB M>QFBKQ @LJBP QL ABSBILM PQOLKD CBBIFKDP CLO QEB QEBO>MFPQoJ>VB MLPFQFSB CBBIFKDP,J>VB KBD>QFSB CBBIFKDP. OBRA @>IIBA QEFP  transference: QEB M>QFBKQ QO>KPCBOP >II QEB MLPFQFSB LO KBD>QFSBBJLQFLKP >PPL@F>QBA TFQE QEB M>QFBKQsP LQEBO OBI>QFLKPEFMP QL QEB MPV@EL>K>IVPQ. LO BU>JMIB, OVPQ>I FPPBBFKD > MPV@EL>K>IVPQ. ROFKD QEB VB>OP LC QEBO>MV, PEB @LJBP QL PBB EBO QEBO>MFPQ >P > C>QEBO CFDROB. EBQO>KPCBOP EBO CBBIFKDP >LRQ EBO C>QEBO LKQL EBO QEBO>MFPQ, MBOE>MP FK >K BCCLOQ QL D>FK QEB ILSB >KA >QQBKQFLKPEB AFA KLQ OB@BFSB COLJ EBO LTK C>QEBO.

    #E>MQBO 16 EBO>MV >KA OB>QJBKQ 617

  • 8/20/2019 Terapia y Tratamiento

    10/134

    Figure 16.9 EFP FP QEB C>JLRP @LR@E FK OBRAhP @LKPRIQFKD OLLJ. >QFBKQP TBOB FKPQOR@QBA QL IFB @LJCLOQ>IV LK QEB

    @LR@E >KA QL C>@B >T>V COLJ OBRA FK LOABO QL CBBI IBPP FKEFFQBA >KA QL EBIM QEBJ CL@RP. LA>V, > MPV@ELQEBO>MV

    M>QFBKQ FP KLQ IFHBIV QL IFB LK > @LR@E; FKPQB>A EB FP JLOB IFHBIV QL PFQ C>@FKD QEB QEBO>MFPQ (OL@E>PH> & LO@OLPP,

    2010). (@OBAFQ: LBOQ RCCPQRQQBO)

    LA>V, OBRAsP MPV@EL>K>IVQF@>I MBOPMB@QFSB E>P BBK BUM>KABA RMLK V QEB ABSBILMJBKQP LC PRPBNRBKQQEBLOFBP >KA JBQELALILDFBP: QEB MPV@ELAVK>JF@ MBOPMB@QFSB. EFP >MMOL>@E QL QEBO>MV OBJ>FKP @BKQBOBALK QEB OLIB LC MBLMIBsP FKQBOK>I AOFSBP >KA CLO@BP, RQ QOB>QJBKQ FP IBPP FKQBKPFSB QE>K OBRAsP LOFDFK>IJLABI.

    FBT > brief video (http://openstaxcollege.org/l/psycanalysis) QE>Q MOBPBKQP >K

    LSBOSFBT LC MPV@EL>K>IVPFP QEBLOV, OBPB>O@E, >KA MO>@QF@B.

    PSYCHOTHERAPY: PLAY THERAPY

    Play therapy FP LCQBK RPBA TFQE @EFIAOBK PFK@B QEBV >OB KLQ IFHBIV QL PFQ LK > @LR@E >KA OB@>II QEBFO AOB>JPLO BKD>DB FK QO>AFQFLK>I Q>IH QEBO>MV. EFP QB@EKFNRB RPBP > QEBO>MBRQF@ MOL@BPP LC MI>V QL pEBIM @IFBKQPMOBSBKQ LO OBPLISB MPV@ELPL@F>I AFCCF@RIQFBP >KA >@EFBSB LMQFJ>I DOLTQEq (sLKKLO, 2000, M. 7). EBFAB> FP QE>Q @EFIAOBK MI>V LRQ QEBFO ELMBP, C>KQ>PFBP, >KA QO>RJ>P TEFIB RPFKD ALIIP, PQRCCBA >KFJ>IP, >KAP>KALU CFDROFKBP (Figure 16.10). I>V QEBO>MV @>K >IPL B RPBA QL EBIM > QEBO>MFPQ J>HB > AF>DKLPFP. EBQEBO>MFPQ LPBOSBP ELT QEB @EFIA FKQBO>@QP TFQE QLVP (B.D., ALIIP, >KFJ>IP, >KA ELJB PBQQFKDP) FK >K BCCLOQQL RKABOPQ>KA QEB OLLQP LC QEB @EFIAsP AFPQROBA BE>SFLO. I>V QEBO>MV @>K B KLKAFOB@QFSB LO [email protected] KLKAFOB@QFSB MI>V QEBO>MV, @EFIAOBK >OB BK@LRO>DBA QL TLOH QEOLRDE QEBFO MOLIBJP V MI>VFKD COBBIVTEFIB QEB QEBO>MFPQ LPBOSBP (BI>K@ & FQ@EFB, 2001). K AFOB@QFSB MI>V QEBO>MV, QEB QEBO>MFPQ MOLSFABPJLOB PQOR@QROB >KA DRFA>K@B FK QEB MI>V PBPPFLK V PRDDBPQFKD QLMF@P, >PHFKD NRBPQFLKP, >KA BSBK MI>VFKDTFQE QEB @EFIA (>OQBO, 1977).

    LINK TO LEARNING

    618 #E>MQBO 16 EBO>MV >KA OB>QJBKQ

    EFP @LKQBKQ FP >S>FI>IB CLO COBB >Q https://cnx.org/content/col11629/1.5

    http://openstaxcollege.org/l/psycanalysishttp://openstaxcollege.org/l/psycanalysis

  • 8/20/2019 Terapia y Tratamiento

    11/134

    Figure 16.10 EFP QVMB LC MI>V QEBO>MV FP HKLTK >P P>KAMI>V LO P>KAQO>V QEBO>MV. #EFIAOBK @>K PBQ RM > QEOBB-

    AFJBKPFLK>I TLOIA RPFKD S>OFLRP CFDROBP >KA LGB@QP QE>Q @LOOBPMLKA QL QEBFO FKKBO PQ>QB (+>ICC, 1991). (@OBAFQ: +OFPQFK>

    >IQBO)

    PSYCHOTHERAPY: BEHAVIOR THERAPY

    K  psychoanalysis, QEBO>MFPQP EBIM QEBFO M>QFBKQP ILLH FKQL QEBFO M>PQ QL RK@LSBO OBMOBPPBA CBBIFKDP. Kbehavior therapy, > QEBO>MFPQ BJMILVP MOFK@FMIBP LC IB>OKFKD QL EBIM @IFBKQP @E>KDB RKABPFO>IB BE>SFLOPoO>QEBO QE>K AFDDFKD ABBMIV FKQL LKBsP RK@LKP@FLRP. EBO>MFPQP TFQE QEFP LOFBKQ>QFLK BIFBSBQE>Q AVPCRK@QFLK>I BE>SFLOP, IFHB MELF>P >KA BATBQQFKD, @>K B @E>KDBA V QB>@EFKD @IFBKQP KBT, JLOB

    @LKPQOR@QFSB BE>SFLOP. BE>SFLO QEBO>MV BJMILVP LQE @I>PPF@>I >KA LMBO>KQ @LKAFQFLKFKD QB@EKFNRBP QL@E>KDB BE>SFLO.

    KB QVMB LC BE>SFLO QEBO>MV RQFIFWBP @I>PPF@>I @LKAFQFLKFKD QB@EKFNRBP. EBO>MFPQP RPFKD QEBPB QB@EKFNRBP BIFBSB QE>Q AVPCRK@QFLK>I BE>SFLOP >OB @LKAFQFLKBA OBPMLKPBP. MMIVFKD QEB @LKAFQFLKFKD MOFK@FMIBPABSBILMBA V S>K >SILS, QEBPB QEBO>MFPQP PBBH QL OB@LKAFQFLK QEBFO @IFBKQP >KA QERP @E>KDB QEBFO BE>SFLO.JJFB FP BFDEQ VB>OP LIA, >KA COBNRBKQIV TBQP EBO BA >Q KFDEQ. EBsP BBK FKSFQBA QL PBSBO>I PIBBMLSBOP, RQ PEB TLKsQ DL B@>RPB LC EBO MOLIBJ. PFKD > QVMB LC @LKAFQFLKFKD QEBO>MV, JJFB BDFKP QL PIBBMLK > IFNRFA-PBKPFQFSB BA M>A QE>Q FP ELLHBA QL >K >I>OJ. EBK JLFPQROB QLR@EBP QEB M>A, FQ PBQP LCC QEB>I>OJ, T>HFKD RM JJFB. EBK QEFP MOL@BPP FP OBMB>QBA BKLRDE QFJBP, JJFB ABSBILMP >K >PPL@F>QFLK BQTBBK ROFK>OV OBI>U>QFLK >KA T>HFKD RM, >KA QEFP PQLMP QEB BATBQQFKD. JJFB E>P KLT DLKB QEOBBTBBHP TFQELRQ TBQQFKD EBO BA >KA FP ILLHFKD CLOT>OA QL EBO CFOPQ PIBBMLSBO QEFP TBBHBKA.

    KB @LJJLKIV RPBA @I>PPF@>I @LKAFQFLKFKD QEBO>MBRQF@ QB@EKFNRB FP counterconditioning: > @IFBKQ IB>OKP >KBT OBPMLKPB QL > PQFJRIRP QE>Q E>P MOBSFLRPIV BIF@FQBA >K RKABPFO>IB BE>SFLO. TL @LRKQBO@LKAFQFLKFKDQB@EKFNRBP >OB >SBOPFSB @LKAFQFLKFKD >KA BUMLPROB QEBO>MV. Aversive conditioning RPBP >K RKMIB>P>KQPQFJRIRP QL PQLM >K RKABPFO>IB BE>SFLO. EBO>MFPQP >MMIV QEFP QB@EKFNRB QL BIFJFK>QB >AAF@QFSB BE>SFLOP,PR@E >P PJLHFKD, K>FI FQFKD, >KA AOFKHFKD. K >SBOPFLK QEBO>MV, @IFBKQP TFII QVMF@>IIV BKD>DB FK > PMB@FCF@ BE>SFLO (PR@E >P K>FI FQFKD) >KA >Q QEB P>JB QFJB >OB BUMLPBA QL PLJBQEFKD RKMIB>P>KQ, PR@E >P >JFIA BIB@QOF@ PEL@H LO > >A Q>PQB. CQBO OBMB>QBA >PPL@F>QFLKP BQTBBK QEB RKMIB>P>KQ PQFJRIRP >KA QEB BE>SFLO, QEB @IFBKQ @>K IB>OK QL PQLM QEB RKT>KQBA BE>SFLO.

    SBOPFLK QEBO>MV E>P BBK RPBA BCCB@QFSBIV CLO VB>OP FK QEB QOB>QJBKQ LC >I@LELIFPJ (>SFAPLK, 1974;IHFKP, 1991; QOBBQLK & EBI>K, 2001). KB @LJJLK T>V QEFP L@@ROP FP QEOLRDE > @EBJF@>IIV >PBAPRPQ>K@B HKLTK >P KQ>RPB. EBK > MBOPLK Q>HBP KQ>RPB >KA QEBK @LKPRJBP >I@LELI, RK@LJCLOQ>IB

    PFAB BCCB@QP OBPRIQ FK@IRAFKD K>RPB>, SLJFQFKD, FK@OB>PBA EB>OQ O>QB, EB>OQ M>IMFQ>QFLKP, PBSBOB EB>A>@EB,>KA PELOQKBPP LC OB>QE. KQ>RPB FP OBMB>QBAIV M>FOBA TFQE >I@LELI RKQFI QEB @IFBKQ >PPL@F>QBP >I@LELITFQE RKMIB>P>KQ CBBIFKDP, TEF@E AB@OB>PBP QEB @IFBKQsP ABPFOB QL @LKPRJB >I@LELI. KQ>RPB @OB>QBP >@LKAFQFLKBA >SBOPFLK QL >I@LELI B@>RPB FQ OBMI>@BP QEB LOFDFK>I MIB>PROB OBPMLKPB TFQE >K RKMIB>P>KQ LKB.

    K exposure therapy, > QEBO>MFPQ PBBHP QL QOB>Q @IFBKQPs CB>OP LO >KUFBQV V MOBPBKQFKD QEBJ TFQE QEB LGB@QLO PFQR>QFLK QE>Q @>RPBP QEBFO MOLIBJ, TFQE QEB FAB> QE>Q QEBV TFII BSBKQR>IIV DBQ RPBA QL FQ. EFP @>K BALKB SF> OB>IFQV, FJ>DFK>QFLK, LO SFOQR>I OB>IFQV. UMLPROB QEBO>MV T>P CFOPQ OBMLOQBA FK 1924 V >OV LSBO *LKBP, TEL FP @LKPFABOBA QEB JLQEBO LC BE>SFLO QEBO>MV. *LKBP TLOHBA TFQE > LV K>JBA BQBO TEL T>P>CO>FA LC O>FQP. BO DL>I T>P QL OBMI>@B BQBOsP CB>O LC O>FQP TFQE > @LKAFQFLKBA OBPMLKPB LC OBI>U>QFLK,

    #E>MQBO 16 EBO>MV >KA OB>QJBKQ 619

  • 8/20/2019 Terapia y Tratamiento

    12/134

    TEF@E FP > OBPMLKPB QE>Q FP FK@LJM>QFIB TFQE CB>O (Figure 16.11). LT AFA PEB AL FQ? *LKBP BD>K VMI>@FKD > @>DBA O>FQ LK QEB LQEBO PFAB LC > OLLJ TFQE BQBO TEFIB EB >QB EFP >CQBOKLLK PK>@H. SBO QEB@LROPB LC PBSBO>I A>VP, *LKBP JLSBA QEB O>FQ @ILPBO >KA @ILPBO QL TEBOB BQBO T>P PB>QBA TFQE EFP PK>@H.CQBO QTL JLKQEP LC BFKD BUMLPBA QL QEB O>FQ TEFIB OBI>UFKD TFQE EFP PK>@H, BQBO T>P >IB QL ELIA QEBO>FQ >KA MBQ FQ TEFIB B>QFKD (*LKBP, 1924).

    Figure 16.11 UMLPROB QEBO>MV PBBHP QL @E>KDB QEB OBPMLKPB QL > @LKAFQFLKBA PQFJRIRP (#). !K RK@LKAFQFLKBA

    PQFJRIRP FP MOBPBKQBA LSBO >KA LSBO GRPQ >CQBO QEB MOBPBKQ>QFLK LC QEB @LKAFQFLKBA PQFJRIRP. EFP CFDROB PELTP

    @LKAFQFLKFKD >P @LKAR@QBA FK >OV #LSBO *LKBPh 1924 PQRAV.

    EFOQV VB>OP I>QBO, *LPBME LIMB (1958) OBCFKBA *LKBPsP QB@EKFNRBP, DFSFKD RP QEB BE>SFLO QEBO>MVQB@EKFNRB LC BUMLPROB QEBO>MV QE>Q FP RPBA QLA>V. MLMRI>O CLOJ LC BUMLPROB QEBO>MV FP  systematicdesensitization, TEBOBFK > @>IJ >KA MIB>P>KQ PQ>QB FP DO>AR>IIV >PPL@F>QBA TFQE FK@OB>PFKD IBSBIP LC >KUFBQV-FKAR@FKD PQFJRIF. EB FAB> FP QE>Q VLR @>KsQ B KBOSLRP >KA OBI>UBA >Q QEB P>JB QFJB. EBOBCLOB, FC VLR @>K IB>OK QL OBI>U TEBK VLR >OB C>@FKD BKSFOLKJBKQ>I PQFJRIF QE>Q J>HB VLR KBOSLRP LO CB>OCRI, VLR@>K BSBKQR>IIV BIFJFK>QB VLRO RKT>KQBA CB>O OBPMLKPB (LIMB, 1958) (Figure 16.12).

    620 #E>MQBO 16 EBO>MV >KA OB>QJBKQ

    EFP @LKQBKQ FP >S>FI>IB CLO COBB >Q https://cnx.org/content/col11629/1.5

  • 8/20/2019 Terapia y Tratamiento

    13/134

    Figure 16.12 EFP MBOPLK PRCCBOP COLJ >O>@EKLMELF> (CB>O LC PMFABOP). EOLRDE BUMLPROB QEBO>MV EB FP IB>OKFKD

    ELT QL C>@B EFP CB>O FK > @LKQOLIIBA, QEBO>MBRQF@ PBQQFKD. (@OBAFQ: iLIIVCLO@B e FSFKD V LOPQ FDEQJ>OBj/IF@HO)

    LT ALBP BUMLPROB QEBO>MV TLOH? *>VABK FP QBOOFCFBA LC BIBS>QLOP. LQEFKD >A E>P BSBO E>MMBKBA QL EFJLK >K BIBS>QLO, RQ EBsP PL >CO>FA LC BIBS>QLOP QE>Q EB TFII >IT>VP Q>HB QEB PQ>FOP. E>Q T>PKsQ > MOLIBJTEBK *>VABK TLOHBA LK QEB PB@LKA CILLO LC >K LCCF@B RFIAFKD, RQ KLT EB E>P > KBT GLoLK QEB 29QECILLO LC > PHVP@O>MBO FK ALTKQLTK LP KDBIBP. *>VABK HKLTP EB @>KsQ @IFJ 29 CIFDEQP LC PQ>FOP FK LOABO QLDBQ QL TLOH B>@E A>V, PL EB AB@FABA QL PBB > BE>SFLO QEBO>MFPQ CLO EBIM. EB QEBO>MFPQ >PHP *>VABK QL CFOPQ@LKPQOR@Q > EFBO>O@EV LC BIBS>QLO-OBI>QBA PFQR>QFLKP QE>Q BIF@FQ CB>O >KA >KUFBQV. EBV O>KDB COLJ PFQR>QFLKP

    LC JFIA >KUFBQV PR@E >P BFKD KBOSLRP >OLRKA QEB LQEBO MBLMIB FK QEB BIBS>QLO, QL QEB CB>O LC DBQQFKD >K >OJ@>RDEQ FK QEB ALLO, QL M>KF@-MOLSLHFKD PFQR>QFLKP PR@E >P DBQQFKD QO>MMBA LO QEB @>IB PK>MMFKD. BUQ, QEBQEBO>MFPQ RPBP MOLDOBPPFSB OBI>U>QFLK. EB QB>@EBP *>VABK ELT QL OBI>U B>@E LC EFP JRP@IB DOLRMP PL QE>QEB >@EFBSBP > AOLTPV, OBI>UBA, >KA @LJCLOQ>IB PQ>QB LC JFKA. K@B EBsP FK QEFP PQ>QB, PEB >PHP *>VABK QLFJ>DFKB > JFIAIV >KUFBQV-MOLSLHFKD PFQR>QFLK. *>VABK FP PQ>KAFKD FK COLKQ LC QEB BIBS>QLO QEFKHFKD >LRQMOBPPFKD QEB @>II RQQLK.

    C QEFP P@BK>OFL @>RPBP *>VABK >KUFBQV, EB IFCQP EFP CFKDBO. EB QEBO>MFPQ TLRIA QEBK QBII *>VABK QL CLODBQQEB P@BKB >KA OBQROK QL EFP OBI>UBA PQ>QB. EB OBMB>QP QEFP P@BK>OFL LSBO >KA LSBO RKQFI *>VABK @>K FJ>DFKBEFJPBIC MOBPPFKD QEB @>II RQQLK TFQELRQ >KUFBQV. SBO QFJB QEB QEBO>MFPQ >KA *>VABK RPB MOLDOBPPFSBOBI>U>QFLK >KA FJ>DFK>QFLK QL MOL@BBA QEOLRDE >II LC QEB PFQR>QFLKP LK *>VABKsP EFBO>O@EV RKQFI EB B@LJBPABPBKPFQFWBA QL B>@E LKB. CQBO QEFP, *>VABK >KA QEB QEBO>MFPQ BDFK QL MO>@QF@B TE>Q EB LKIV MOBSFLRPIVBKSFPFLKBA FK QEBO>MV, DO>AR>IIV DLFKD COLJ MOBPPFKD QEB RQQLK QL >@QR>IIV OFAFKD >K BIBS>QLO. EB DL>IFP QE>Q *>VABK TFII PLLK B >IB QL Q>HB QEB BIBS>QLO >II QEB T>V RM QL QEB 29QE CILLO LC EFP LCCF@B TFQELRQCBBIFKD >KV >KUFBQV.

    LJBQFJBP, FQsP QLL FJMO>@QF@>I, BUMBKPFSB, LO BJ>OO>PPFKD QL OB-@OB>QB >KUFBQV- MOLAR@FKD PFQR>QFLKP, PL> QEBO>MFPQ JFDEQ BJMILV virtual reality exposure therapy V RPFKD > PFJRI>QFLK QL EBIM @LKNRBO CB>OP.FOQR>I OB>IFQV BUMLPROB QEBO>MV E>P BBK RPBA BCCB@QFSBIV QL QOB>Q KRJBOLRP >KUFBQV AFPLOABOP PR@E >PQEB CB>O LC MRIF@ PMB>HFKD, @I>RPQOLMELF> (CB>O LC BK@ILPBA PM>@BP), >SFLMELF> (CB>O LC CIVFKD), >KA MLPQ-QO>RJ>QF@ PQOBPP AFPLOABO (), > QO>RJ> >KA PQOBPPLO-OBI>QBA AFPLOABO (BO>OAF, RHLO, FCBAB, FWWL, &LQE>RJ, 2010).

    ! KBT SFOQR>I OB>IFQV BUMLPROB QEBO>MV FP BFKD RPBA QL QOB>Q FK PLIAFBOP. FOQR>I

    O>N FP > PFJRI>QFLK QE>Q JFJF@P FAAIB >PQBOK @FQFBP >KA ABPBOQ OL>AP TFQE PFQR>QFLKP

    PFJFI>O QL QELPB PLIAFBOP BUMBOFBK@BA TEFIB ABMILVBA FK O>N. EFP JBQELA LC SFOQR>I

    OB>IFQV BUMLPROB QEBO>MV E>P BBK BCCB@QFSB FK QOB>QFKD CLO @LJ>Q SBQBO>KP.

    !MMOLUFJ>QBIV 80% LC M>OQF@FM>KQP TEL @LJMIBQBA QOB>QJBKQ P>T @IFKF@>IIV PFDKFCF@>KQ

    OBAR@QFLK FK QEBFO PVJMQLJP LC , >KUFBQV, >KA ABMOBPPFLK (FWWL BQ >I., 2010). >Q@E QEFP Virtual Iraq

    video (http://openstaxcollege.org/l/virIraq) PELTFKD PLIAFBOP BFKD QOB>QBA SF> PFJRI>QFLK.

    LINK TO LEARNING

    #E>MQBO 16 EBO>MV >KA OB>QJBKQ 621

    http://openstaxcollege.org/l/virIraqhttp://openstaxcollege.org/l/virIraqhttp://openstaxcollege.org/l/virIraqhttp://openstaxcollege.org/l/virIraq

  • 8/20/2019 Terapia y Tratamiento

    14/134

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

     RIBP, >KA BUQO> MI>V QFJB) >OB RPBA QL OBT>OA >KA JLQFS>QB >RQFPQF@ @EFIAOBK TEBK QEBV ABJLKPQO>QBABPFOBA BE>SFLOP PR@E >P PFQQFKD LK > @E>FO TEBK OBNRBPQBA, SBO>IFWFKD > DOBBQFKD, LO J>HFKD BVB @LKQ>@Q.RKFPEJBKQ PR@E >P > QFJBLRQ LO > PE>OM pL!q COLJ QEB QEBO>MFPQ LO M>OBKQ JFDEQ B RPBA QL AFP@LRO>DBRKABPFO>IB BE>SFLOP PR@E >P MFK@EFKD, P@O>Q@EFKD, >KA MRIIFKD E>FO.

    KB MLMRI>O LMBO>KQ @LKAFQFLKFKD FKQBOSBKQFLK FP @>IIBA QEB token economy. EFP FKSLISBP > @LKQOLIIBAPBQQFKD TEBOB FKAFSFAR>IP >OB OBFKCLO@BA CLO ABPFO>IB BE>SFLOP TFQE QLHBKP, PR@E >P > MLHBO @EFM, QE>Q @>K B BU@E>KDBA CLO FQBJP LO MOFSFIBDBP. LHBK B@LKLJFBP >OB LCQBK RPBA FK MPV@EF>QOF@ ELPMFQ>IP QL FK@OB>PBM>QFBKQ @LLMBO>QFLK >KA >@QFSFQV IBSBIP. >QFBKQP >OB OBT>OABA TFQE QLHBKP TEBK QEBV BKD>DB FK MLPFQFSB BE>SFLOP (B.D., J>HFKD QEBFO BAP, ORPEFKD QEBFO QBBQE, @LJFKD QL QEB @>CBQBOF> LK QFJB, >KA PL@F>IFWFKDTFQE LQEBO M>QFBKQP). EBV @>K I>QBO BU@E>KDB QEB QLHBKP CLO BUQO> QFJB, MOFS>QB OLLJP, SFPFQP QL QEB@>KQBBK, >KA PL LK (F@HBOPLK, BKERI>, & OBBK->ABK, 2005).

    PSYCHOTHERAPY: COGNITIVE THERAPY

    Cognitive therapy FP > CLOJ LC MPV@ELQEBO>MV QE>Q CL@RPBP LK ELT > MBOPLKs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sPDLFKD QL C>FI QEB BKQFOB @LROPB >KA MOL>IV CIRKH LRQ LC @LIIBDB >IQLDBQEBO. EBPB BOOLOP FK QEFKHFKD E>SB@LKQOFRQBA QL >VsP CBBIFKDP LC AFPQOBPP. FP QEBO>MFPQ TFII EBIM EFJ @E>IIBKDB QEBPB FOO>QFLK>I BIFBCP, CL@RP

    LK QEBFO FIILDF@>I >PFP, >KA @LOOB@Q QEBJ TFQE JLOB ILDF@>I >KA O>QFLK>I QELRDEQP >KA BIFBCP.LDKFQFSB QEBO>MV T>P ABSBILMBA V MPV@EF>QOFPQ >OLK B@H FK QEB 1960P. FP FKFQF>I CL@RP T>P LKABMOBPPFLK >KA ELT > @IFBKQsP PBIC-ABCB>QFKD >QQFQRAB PBOSBA QL J>FKQ>FK > ABMOBPPFLK ABPMFQB MLPFQFSBC>@QLOP FK EBO IFCB (B@H, RPE, E>T, & JBOV, 1979) (Figure 16.13). EOLRDE NRBPQFLKFKD, > @LDKFQFSBQEBO>MFPQ @>K EBIM > @IFBKQ OB@LDKFWB AVPCRK@QFLK>I FAB>P, @E>IIBKDB @>Q>PQOLMEFWFKD QELRDEQP >LRQQEBJPBISBP >KA QEBFO PFQR>QFLKP, >KA CFKA > JLOB MLPFQFSB T>V QL SFBT QEFKDP (B@H, 2011).

    622 #E>MQBO 16 EBO>MV >KA OB>QJBKQ

    EFP @LKQBKQ FP >S>FI>IB CLO COBB >Q https://cnx.org/content/col11629/1.5

  • 8/20/2019 Terapia y Tratamiento

    15/134

    Figure 16.13 LRO BJLQFLK>I OB>@QFLKP >OB QEB OBPRIQ LC VLRO QELRDEQP >LRQ QEB PFQR>QFLK O>QEBO QE>K QEB PFQR>QFLK

    FQPBIC. LO FKPQ>K@B, FC VLR @LKPFPQBKQIV FKQBOMOBQ BSBKQP >KA BJLQFLKP >OLRKA QEB QEBJBP LC ILPP >KA ABCB>Q, QEBK VLR

    >OB IFHBIV QL B ABMOBPPBA. EOLRDE QEBO>MV, VLR @>K IB>OK JLOB ILDF@>I T>VP QL FKQBOMOBQ PFQR>QFLKP.

    FBT > OFBC SFABL FK TEF@E Judith Beck talks about cognitive therapy

    (http://openstaxcollege.org/l/JBeck)>KA @LKAR@QP > PBPPFLK TFQE > @IFBKQ.

    PSYCHOTHERAPY: COGNITIVE-BEHAVIORAL THERAPY

    LDKFQFSB-BE>SFLO>I QEBO>MFPQP CL@RP JR@E JLOB LK MOBPBKQ FPPRBP QE>K LK > M>QFBKQsP @EFIAELLA LO M>PQ,>P FK LQEBO CLOJP LC MPV@ELQEBO>MV. KB LC QEB CFOPQ CLOJP LC @LDKFQFSB-BE>SFLO>I QEBO>MV T>P  rationalemotive therapy (RET), TEF@E T>P CLRKABA V IBOQ IIFP >KA DOBT LRQ LC EFP AFPIFHB LC OBRAF>K

    MPV@EL>K>IVPFP (>KFBI, K.A.). BE>SFLOFPQP PR@E >P *LPBME LIMB >IPL FKCIRBK@BA IIFPsP QEBO>MBRQF@>MMOL>@E (>QFLK>I PPL@F>QFLK LC LDKFQFSB-BE>SFLO>I EBO>MFPQP, 2009).

    Cognitive-behavioral therapy (CBT) 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

    CLRKA QL B BCCB@QFSB FK AB@OB>PFKD IBSBIP LC ELMBIBPPKBPP >KA PRF@FA>I QELRDEQP FK MOBSFLRPIV PRF@FA>IQBBK>DBOP (I>SF, E>OFCF, E>KFW>ABE, & BELWLODF, 2013). LDKFQFSB-BE>SFLO>I QEBO>MV E>P >IPL BBKBCCB@QFSB FK OBAR@FKD FK PMB@FCF@ MLMRI>QFLKP, PR@E >P QO>KPFQ TLOHBOP (LTFKDBO & LJLJ, 2012).

    LDKFQFSB-BE>SFLO>I QEBO>MV >FJP QL @E>KDB @LDKFQFSB AFPQLOQFLKP >KA PBIC-ABCB>QFKD BE>SFLOP RPFKDQB@EKFNRBP IFHB QEB JLABI. FQE QEFP JLABI, QEBOB FP >K A@QFLK (PLJBQFJBP @>IIBA >K >@QFS>QFKD BSBKQ),QEB BBIFBC >LRQ QEB BSBKQ, >KA QEB CLKPBNRBK@BP LC QEFP BIFBC. BQsP P>V, *LK >KA *LB LQE DL QL > M>OQV. *LK>KA *LB B>@E E>SB JBQ > VLRKD TLJ>K >Q QEB M>OQV: *LK FP Q>IHFKD TFQE BD>K JLPQ LC QEB M>OQV, >KA *LB FPQ>IHFKD TFQE J>KA>. Q QEB BKA LC QEB M>OQV, *LK >PHP BD>K CLO EBO MELKB KRJBO >KA *LB >PHP J>KA>.BD>K QBIIP *LK PEB TLRIA O>QEBO KLQ DFSB EFJ EBO KRJBO, >KA J>KA> QBIIP *LB QEB P>JB QEFKD. LQE

    LINK TO LEARNING

    #E>MQBO 16 EBO>MV >KA OB>QJBKQ 623

    http://openstaxcollege.org/l/JBeckhttp://openstaxcollege.org/l/JBeckhttp://openstaxcollege.org/l/JBeckhttp://openstaxcollege.org/l/JBeck

  • 8/20/2019 Terapia y Tratamiento

    16/134

     *LK >KA *LB >OB PROMOFPBA, >P QEBV QELRDEQ QEFKDP TBOB DLFKD TBII. E>Q @>K *LK >KA *LB QBII QEBJPBISBP>LRQ TEV QEB TLJBK TBOB KLQ FKQBOBPQBA? BQsP P>V *LK QBIIP EFJPBIC EB FP > ILPBO, LO FP RDIV, LO pE>P KLD>JB.q *LK QEBK DBQP ABMOBPPBA >KA AB@FABP KLQ QL DL QL >KLQEBO M>OQV, TEF@E PQ>OQP > @V@IB QE>Q HBBMP EFJABMOBPPBA. *LB QBIIP EFJPBIC QE>Q EB E>A >A OB>QE, DLBP LRQ >KA RVP > KBT QLLQEORPE, DLBP QL >KLQEBOM>OQV, >KA JBBQP PLJBLKB KBT.

     *LKsP BIFBC >LRQ TE>Q E>MMBKBA OBPRIQP FK > @LKPBNRBK@B LC CROQEBO ABMOBPPFLK, TEBOB>P *LBsP BIFBC 

    ALBP KLQ. *LK FP FKQBOK>IFWFKD QEB >QQOFRQFLK LO OB>PLK CLO QEB OBRCCP, TEF@E QOFDDBOP EFP ABMOBPPFLK.K QEB LQEBO E>KA, *LB FP BUQBOK>IFWFKD QEB @>RPB, PL EFP QEFKHFKD ALBP KLQ @LKQOFRQB QL CBBIFKDP LC ABMOBPPFLK. LDKFQFSB-BE>SFLO>I QEBO>MV BU>JFKBP PMB@FCF@ J>I>A>MQFSB >KA >RQLJ>QF@ QELRDEQP >KA@LDKFQFSB AFPQLOQFLKP. LJB BU>JMIBP LC @LDKFQFSB AFPQLOQFLKP >OB >II-LO-KLQEFKD QEFKHFKD,LSBODBKBO>IFW>QFLK, >KA GRJMFKD QL @LK@IRPFLKP. K LSBODBKBO>IFW>QFLK, PLJBLKB Q>HBP > PJ>II PFQR>QFLK>KA J>HBP FQ ERDBoCLO BU>JMIB, FKPQB>A LC P>VFKD, pEFP M>OQF@RI>O TLJ>K T>P KLQ FKQBOBPQBA FK JB,q QEBJ>K P>VP, p >J RDIV, > ILPBO, >KA KL LKB FP BSBO DLFKD QL B FKQBOBPQBA FK JB.q

    II LO KLQEFKD QEFKHFKD, TEF@E FP > @LJJLK QVMB LC @LDKFQFSB AFPQLOQFLK CLO MBLMIB PRCCBOFKD COLJABMOBPPFLK, OBCIB@QP BUQOBJBP. K LQEBO TLOAP, BSBOVQEFKD FP I>@H LO TEFQB. CQBO BFKD QROKBA ALTK CLO >A>QB, *LK BDFKP QL QEFKH, pL TLJ>K TFII BSBO DL LRQ TFQE JB. sJ DLFKD QL B >ILKB CLOBSBO.q B BDFKPQL CBBI >KUFLRP >KA P>A >P EB @LKQBJMI>QBP EFP CRQROB.

    EB QEFOA HFKA LC AFPQLOQFLK FKSLISBP GRJMFKD QL @LK@IRPFLKPo>PPRJFKD QE>Q MBLMIB >OB QEFKHFKDKBD>QFSBIV >LRQ VLR LO OB>@QFKD KBD>QFSBIV QL VLR, BSBK QELRDE QEBOB FP KL BSFABK@B. LKPFABO QEBBU>JMIB LC >S>KK>E >KA FII>FOB, TEL OB@BKQIV JBQ >Q > M>OQV. EBV E>SB > ILQ FK @LJJLK, >KA >S>KK>EQEFKHP QEBV @LRIA B@LJB COFBKAP. EB @>IIP FII>FOB QL FKSFQB EBO CLO @LCCBB. FK@B FII>FOB ALBPKsQ >KPTBO,>S>KK>E IB>SBP EBO > JBPP>DB. BSBO>I A>VP DL V >KA >S>KK>E KBSBO EB>OP >@H COLJ EBO MLQBKQF>I KBTCOFBKA. >VB FII>FOB KBSBO OB@BFSBA QEB JBPP>DB B@>RPB PEB ILPQ EBO MELKB LO PEB FP QLL RPV QL OBQROKQEB MELKB @>II. RQ FC >S>KK>E BIFBSBP QE>Q FII>FOB AFAKsQ IFHB >S>KK>E LO AFAKsQ T>KQ QL B EBO COFBKA,PEB FP ABJLKPQO>QFKD QEB @LDKFQFSB AFPQLOQFLK LC GRJMFKD QL @LK@IRPFLKP.

    LT BCCB@QFSB FP ? KB @IFBKQ P>FA QEFP >LRQ EFP @LDKFQFSB-BE>SFLO>I QEBO>MV:

    E>SB E>A J>KV M>FKCRI BMFPLABP LC ABMOBPPFLK FK JV IFCB, >KA QEFP E>P E>A > KBD>QFSB BCCB@QLK JV @>OBBO >KA E>P MRQ @LKPFABO>IB PQO>FK LK JV COFBKAP >KA C>JFIV. EB QOB>QJBKQP E>SB

    OB@BFSBA, PR@E >P Q>HFKD >KQFABMOBPP>KQP >KA MPV@ELAVK>JF@ @LRKPBIFKD, E>SB EBIMBA JB< QL@LMB TFQE QEB PVJMQLJP >KA QL DBQ PLJB FKPFDEQP FKQL QEB OLLQP LC JV MOLIBJP. E>P BBK V C>O QEB JLPQ RPBCRI >MMOL>@E E>SB CLRKA FK Q>@HIFKD QEBPB JLLA MOLIBJP. Q E>P O>FPBAJV >T>OBKBPP LC ELT JV QELRDEQP FJM>@Q LK JV JLLAP. LT QEB T>V QEFKH >LRQ JVPBIC,>LRQ LQEBOP >KA >LRQ QEB TLOIA @>K IB>A JB FKQL ABMOBPPFLK. Q FP > MO>@QF@>I >MMOL>@E, TEF@EALBP KLQ ATBII PL JR@E LK @EFIAELLA BUMBOFBK@BP, TEFIPQ >@HKLTIBADFKD QE>Q FQ T>P QEBK QE>QQEBPB M>QQBOKP TBOB IB>OKBA. Q ILLHP >Q TE>Q FP E>MMBKFKD KLT, >KA DFSBP QLLIP QL J>K>DB QEBPBJLLAP LK > A>FIV >PFP. (>OQFK, 2007, K.M.)

    PSYCHOTHERAPY: HUMANISTIC THERAPY

    RJ>KFPQF@ MPV@ELILDV CL@RPBP LK EBIMFKD MBLMIB >@EFBSB QEBFO MLQBKQF>I. L FQ J>HBP PBKPB QE>Q QEB DL>ILC  humanistic therapy FP QL EBIM MBLMIB B@LJB JLOB PBIC->T>OB >KA >@@BMQFKD LC QEBJPBISBP. K @LKQO>PQQL MPV@EL>K>IVPFP, ERJ>KFPQF@ QEBO>MFPQP CL@RP LK @LKP@FLRP O>QEBO QE>K RK@LKP@FLRP QELRDEQP. EBV >IPLBJME>PFWB QEB M>QFBKQsP MOBPBKQ >KA CRQROB, >P LMMLPBA QL BUMILOFKD QEB M>QFBKQsP M>PQ.

    PV@ELILDFPQ >OI LDBOP ABSBILMBA > QEBO>MBRQF@ LOFBKQ>QFLK HKLTK >P  Rogerian, LO  client-centeredtherapy. LQB QEB @E>KDB COLJ  patients QL clients. LDBOP (1951) CBIQ QE>Q QEB QBOJ M>QFBKQ PRDDBPQBA QEBMBOPLK PBBHFKD EBIM T>P PF@H >KA ILLHFKD CLO > @ROB. FK@B QEFP FP > CLOJ LC  nondirective therapy, >QEBO>MBRQF@ >MMOL>@E FK TEF@E QEB QEBO>MFPQ ALBP KLQ DFSB >ASF@B LO MOLSFAB FKQBOMOBQ>QFLKP RQ EBIMPQEB MBOPLK QL FABKQFCV @LKCIF@QP >KA RKABOPQ>KA CBBIFKDP, LDBOP (1951) BJME>PFWBA QEB FJMLOQ>K@B LC QEBMBOPLK Q>HFKD @LKQOLI LC EFP LTK IFCB QL LSBO@LJB IFCBsP @E>IIBKDBP.

    624 #E>MQBO 16 EBO>MV >KA OB>QJBKQ

    EFP @LKQBKQ FP >S>FI>IB CLO COBB >Q https://cnx.org/content/col11629/1.5

  • 8/20/2019 Terapia y Tratamiento

    17/134

    K @IFBKQ-@BKQBOBA QEBO>MV, QEB QEBO>MFPQ RPBP QEB QB@EKFNRB LC >@QFSB IFPQBKFKD. K >@QFSB IFPQBKFKD, QEBQEBO>MFPQ >@HKLTIBADBP, OBPQ>QBP, >KA @I>OFCFBP TE>Q QEB @IFBKQ BUMOBPPBP. EBO>MFPQP >IPL MO>@QF@B TE>QLDBOP @>IIBA  unconditional positive regard, TEF@E FKSLISBP KLQ GRADFKD @IFBKQP >KA PFJMIV >@@BMQFKDQEBJ CLO TEL QEBV >OB. LDBOP (1951) >IPL CBIQ QE>Q QEBO>MFPQP PELRIA ABJLKPQO>QB DBKRFKBKBPP, BJM>QEV,>KA >@@BMQ>K@B QLT>OA QEBFO @IFBKQP B@>RPB QEFP EBIMP MBLMIB B@LJB JLOB >@@BMQFKD LC QEBJPBISBP, TEF@EOBPRIQP FK MBOPLK>I DOLTQE.

    EVALUATING VARIOUS FORMS OF PSYCHOTHERAPY

    LT @>K TB >PPBPP QEB BCCB@QFSBKBPP LC MPV@ELQEBO>MV? P LKB QB@EKFNRB JLOB BCCB@QFSB QE>K >KLQEBO?LO >KVLKB @LKPFABOFKD QEBO>MV, QEBPB >OB FJMLOQ>KQ NRBPQFLKP. @@LOAFKD QL QEB JBOF@>K PV@ELILDF@>IPPL@F>QFLK, QEOBB C>@QLOP TLOH QLDBQEBO QL MOLAR@B PR@@BPPCRI QOB>QJBKQ. EB CFOPQ FP QEB RPB LC BSFABK@B- >PBA QOB>QJBKQ QE>Q FP ABBJBA >MMOLMOF>QB CLO VLRO M>OQF@RI>O FPPRB. EB PB@LKA FJMLOQ>KQ C>@QLO FP QEB@IFKF@>I BUMBOQFPB LC QEB MPV@ELILDFPQ LO QEBO>MFPQ. EB QEFOA C>@QLO FP VLRO LTK @E>O>@QBOFPQF@P, S>IRBP,MOBCBOBK@BP, >KA @RIQROB. >KV MBLMIB BDFK MPV@ELQEBO>MV CBBIFKD IFHB QEBFO MOLIBJ TFII KBSBO BOBPLISBA; ELTBSBO, MPV@ELQEBO>MV EBIMP MBLMIB PBB QE>Q QEBV @>K AL QEFKDP QL J>HB QEBFO PFQR>QFLK BQQBO.PV@ELQEBO>MV @>K EBIM OBAR@B > MBOPLKsP >KUFBQV, ABMOBPPFLK, >KA J>I>A>MQFSB BE>SFLOP. EOLRDEMPV@ELQEBO>MV, FKAFSFAR>IP @>K IB>OK QL BKD>DB FK EB>IQEV BE>SFLOP ABPFDKBA QL EBIM QEBJ BQQBO BUMOBPPBJLQFLKP, FJMOLSB OBI>QFLKPEFMP, QEFKH JLOB MLPFQFSBIV, >KA MBOCLOJ JLOB BCCB@QFSBIV >Q TLOH LO P@ELLI.

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sP QOB>QJBKQ LRQ@LJB >KA QEB IBSBILC QEB @IFKF@F>KsP QO>FKFKD LO BUMBOFBK@B (>JMLIA, 2007). BD>OAIBPP LC TEF@E QVMB LC MPV@ELQEBO>MV >KFKAFSFAR>I @ELLPBP, LKB @OFQF@>I C>@QLO QE>Q ABQBOJFKBP QEB PR@@BPP LC QOB>QJBKQ FP QEB MBOPLKsP OBI>QFLKPEFM

    TFQE QEB MPV@ELILDFPQ LO QEBO>MFPQ.

    BIOMEDICAL THERAPIES

    KAFSFAR>IP @>K B MOBP@OFBA FLILDF@>IIV >PBA QOB>QJBKQP LO MPV@ELQOLMF@ JBAF@>QFLKP QE>Q >OB RPBAQL QOB>Q JBKQ>I AFPLOABOP. EFIB QEBPB >OB LCQBK RPBA FK @LJFK>QFLK TFQE MPV@ELQEBO>MV, QEBV >IPL>OB Q>HBK V FKAFSFAR>IP KLQ FK QEBO>MV. EFP FP HKLTK >P   biomedical therapy. BAF@>QFLKP RPBA QLQOB>Q MPV@ELILDF@>I AFPLOABOP >OB @>IIBA MPV@ELQOLMF@ JBAF@>QFLKP >KA >OB MOBP@OFBA V JBAF@>I AL@QLOP,FK@IRAFKD MPV@EF>QOFPQP. K LRFPF>K> >KA BT BUF@L, MPV@ELILDFPQP >OB >IB QL MOBP@OFB PLJB QVMBP LC QEBPB JBAF@>QFLKP (JBOF@>K PV@ELILDF@>I PPL@F>QFLK, 2014).

    FCCBOBKQ QVMBP >KA @I>PPBP LC JBAF@>QFLKP >OB MOBP@OFBA CLO AFCCBOBKQ AFPLOABOP. ABMOBPPBA MBOPLK JFDEQ B DFSBK >K >KQFABMOBPP>KQ, > FMLI>O FKAFSFAR>I JFDEQ B DFSBK > JLLA PQ>FIFWBO, >KA > P@EFWLMEOBKF@

    FKAFSFAR>I JFDEQ B DFSBK >K >KQFMPV@ELQF@. EBPB JBAF@>QFLKP QOB>Q QEB PVJMQLJP LC > MPV@ELILDF@>IAFPLOABO. EBV @>K EBIM MBLMIB CBBI BQQBO PL QE>Q QEBV @>K CRK@QFLK LK > A>FIV >PFP, RQ QEBV AL KLQ @ROB QEBAFPLOABO. LJB MBLMIB J>V LKIV KBBA QL Q>HB > MPV@ELQOLMF@ JBAF@>QFLK CLO > PELOQ MBOFLA LC QFJB. QEBOPTFQE PBSBOB AFPLOABOP IFHB FMLI>O AFPLOABO LO P@EFWLMEOBKF> J>V KBBA QL Q>HB MPV@ELQOLMF@ JBAF@>QFLK CLO> ILKD QFJB. Table 16.2 PELTP QEB QVMBP LC JBAF@>QFLK >KA ELT QEBV >OB RPBA.

    #E>MQBO 16 EBO>MV >KA OB>QJBKQ 625

  • 8/20/2019 Terapia y Tratamiento

    18/134

    Table 16.2 Commonly Prescribed Psychotropic Medications

    Type of

    Medication

    Used to

    Treat

    Brand

    Names of

    Commonly

    Prescribed

    Medications

    How They Work Side Effects

    KQFMPV@ELQF@P(ABSBILMBA FKQEB 1950P)

    @EFWLMEOBKF>>KA LQEBOQVMBP LC PBSBOBQELRDEQAFPLOABOP

    >IALI,BII>OFI,OLIFUFK,ELO>WFKB

    OB>Q MLPFQFSB MPV@ELQF@PVJMQLJP PR@E >P>RAFQLOV >KA SFPR>IE>IIR@FK>QFLKP, ABIRPFLKP,>KA M>O>KLF> V IL@HFKDQEB KBROLQO>KPJFQQBOALM>JFKB

    LKD-QBOJ RPB @>KIB>A QL Q>OAFSBAVPHFKBPF>,FKSLIRKQ>OVJLSBJBKQP LC QEB>OJP, IBDP, QLKDRB>KA C>@F>I JRP@IBP,OBPRIQFKD FK>OHFKPLKsP-IFHBQOBJLOP

    QVMF@>IKQFMPV@ELQF@P(ABSBILMBA FKQEB I>QB 1980P)

    @EFWLMEOBKF>>KA LQEBOQVMBP LC PBSBOBQELRDEQAFPLOABOP

    FIFCV,FPMBOA>I,ILW>OFI

    OB>Q QEB KBD>QFSBPVJMQLJP LC P@EFWLMEOBKF>, PR@E >PTFQEAO>T>I >KA >M>QEV, V Q>ODBQFKD LQEALM>JFKB >KA PBOLQLKFKOB@BMQLOP; KBTBOJBAF@>QFLKP J>V QOB>Q LQE MLPFQFSB >KAKBD>QFSB PVJMQLJP

    >K FK@OB>PB QEBOFPH LC LBPFQV >KAAF>BQBP >P TBII >PBIBS>QB @ELIBPQBOLIIBSBIP;@LKPQFM>QFLK, AOVJLRQE, IROOBASFPFLK, AOLTPFKBPP,>KA AFWWFKBPP

    KQF-ABMOBPP>KQP

    BMOBPPFLK>KAFK@OB>PFKDIVCLO >KUFBQV

    >UFI,OLW>@,LILCQ(PBIB@QFSBPBOLQLKFKOBRMQ>HBFKEFFQLOP,PKFI >KAI>SFI(QOF@V@IF@P)

    IQBO IBSBIP LC KBROLQO>KPJFQQBOP PR@E >PPBOLQLKFK >KAKLOBMFKBMEOFKB

    P: EB>A>@EB,K>RPB>, TBFDEQD>FK, AOLTPFKBPP,OBAR@BA PBU AOFSBOF@V@IF@P: AOVJLRQE,@LKPQFM>QFLK, IROOBA SFPFLK,AOLTPFKBPP,OBAR@BA PBU AOFSB,FK@OB>PBA OFPH LC 

    PRF@FAB

    626 #E>MQBO 16 EBO>MV >KA OB>QJBKQ

    EFP @LKQBKQ FP >S>FI>IB CLO COBB >Q https://cnx.org/content/col11629/1.5

  • 8/20/2019 Terapia y Tratamiento

    19/134

    Table 16.2 Commonly Prescribed Psychotropic Medications

    Type of

    Medication

    Used to

    Treat

    Brand

    Names of

    Commonly

    Prescribed

    Medications

    How They Work Side Effects

    KQF->KUFBQV>DBKQP

    KUFBQV >KA>DFQ>QFLK QE>QL@@RO FK, ,M>KF@AFPLOABO, >KAPL@F>I MELF>

    >K>U,>IFRJ,QFS>K

    BMOBPP @BKQO>I KBOSLRPPVPQBJ >@QFSFQV

    OLTPFKBPP,AFWWFKBPP,EB>A>@EB, C>QFDRB,IFDEQEB>ABAKBPP

    LLAQ>FIFWBOP

    FMLI>OAFPLOABO

    FQEFRJ,BM>HLQB,

    >JF@Q>I,BDOBQLI

    OB>Q BMFPLABP LC J>KF>>P TBII >P ABMOBPPFLK

    U@BPPFSB QEFOPQ,FOOBDRI>O

    EB>OQB>Q, FQ@EFKD/O>PE, PTBIIFKD(C>@B, JLRQE, >KABUQOBJFQFBP),K>RPB>, ILPP LC >MMBQFQB

    QFJRI>KQP AABO>II,FQ>IFK

    JMOLSB >FIFQV QL CL@RPLK > Q>PH >KA J>FKQ>FK>QQBKQFLK

    B@OB>PBA>MMBQFQB, AFCCF@RIQVPIBBMFKD,PQLJ>@E>@EB,EB>A>@EB

    KLQEBO FLILDF@>IIV >PBA QOB>QJBKQ QE>Q @LKQFKRBP QL B RPBA, >IQELRDE FKCOBNRBKQIV, FPelectroconvulsive therapy (ECT) (CLOJBOIV HKLTK V FQP RKP@FBKQFCF@ K>JB >P BIB@QOLPEL@H QEBO>MV). QFKSLISBP RPFKD >K BIB@QOF@>I @ROOBKQ QL FKAR@B PBFWROBP QL EBIM >IIBSF>QB QEB BCCB@QP LC PBSBOB ABMOBPPFLK. EBBU>@Q JB@E>KFPJ FP RKHKLTK, >IQELRDE FQ ALBP EBIM >IIBSF>QB PVJMQLJP CLO MBLMIB TFQE PBSBOB ABMOBPPFLKTEL E>SB KLQ OBPMLKABA QL QO>AFQFLK>I AORD QEBO>MV (>DKFK, AB RBFOLW, FKF, & >PP>KL, 2004). LRQ85% LC MBLMIB QOB>QBA TFQE FJMOLSB (BQF, K.A.). LTBSBO, QEB JBJLOV ILPP >PPL@F>QBA TFQE OBMB>QBA>AJFKFPQO>QFLKP E>P IBA QL FQ BFKD FJMIBJBKQBA >P > I>PQ OBPLOQ (LK>ERB, 2000; ORAF@, BVPBO, & >@HBFJ,2000). JLOB OB@BKQ >IQBOK>QFSB FP QO>KP@O>KF>I J>DKBQF@ PQFJRI>QFLK (), > MOL@BAROB >MMOLSBA VQEB FK 2008 QE>Q RPBP J>DKBQF@ CFBIAP QL PQFJRI>QB KBOSB @BIIP FK QEB O>FK QL FJMOLSB ABMOBPPFLKPVJMQLJP; FQ FP RPBA TEBK LQEBO QOB>QJBKQP E>SB KLQ TLOHBA (>VL IFKF@, 2012).

    Evidence-based Practice

    ! RWWTLOA FK QEBO>MV QLA>V FP BSFABK@B->PBA MO>@QF@B. LTBSBO, FQhP KLQ > KLSBI @LK@BMQ RQ LKB QE>Q

    E>P BBK RPBA FK JBAF@FKB CLO >Q IB>PQ QTL AB@>ABP. SFABK@B->PBA MO>@QF@B FP RPBA QL OBAR@B BOOLOP FK

    QOB>QJBKQ PBIB@QFLK V J>HFKD @IFKF@>I AB@FPFLKP >PBA LK OBPB>O@E (>@HBQQ & LPBKBOD, 1995). K >KV @>PB,

    DIG DEEPER

    #E>MQBO 16 EBO>MV >KA OB>QJBKQ 627

  • 8/20/2019 Terapia y Tratamiento

    20/134

    BSFABK@B->PBA QOB>QJBKQ FP LK QEB OFPB FK QEB CFBIA LC MPV@ELILDV. L TE>Q FP FQ, >KA TEV ALBP FQ J>QQBO? K

    >K BCCLOQ QL ABQBOJFKB TEF@E QOB>QJBKQ JBQELALILDFBP >OB BSFABK@BA->PBA, MOLCBPPFLK>I LOD>KFW>QFLKP PR@E

    >P QEB !JBOF@>K PV@ELILDF@>I !PPL@F>QFLK (!!) E>SB OB@LJJBKABA QE>Q PMB@FCF@ MPV@ELILDF@>I QOB>QJBKQP

    B RPBA QL QOB>Q @BOQ>FK MPV@ELILDF@>I AFPLOABOP (#E>JIBPP & IIBKAF@H, 2001). !@@LOAFKD QL QEB !! (2005),

    iSFABK@B->PBA MO>@QF@B FK MPV@ELILDV () FP QEB FKQBDO>QFLK LC QEB BPQ >S>FI>IB OBPB>O@E TFQE @IFKF@>I

    BUMBOQFPB FK QEB @LKQBUQ LC M>QFBKQ @E>O>@QBOFPQF@P, @RIQROB, >KA MOBCBOBK@BPj (M. 1).

    EB CLRKA>QFLK>I FAB> BEFKA BSFABK@B >PBA QOB>QJBKQ FP QE>Q BPQ MO>@QF@BP >OB ABQBOJFKBA V OBPB>O@E

    BSFABK@B QE>Q E>P BBK @LJMFIBA V @LJM>OFKD S>OFLRP CLOJP LC QOB>QJBKQ (#E>OJ>K & >OHE>J, 2005).

    EBPB QOB>QJBKQP >OB QEBK LMBO>QFLK>IFWBA >KA MI>@BA FK QOB>QJBKQ J>KR>IPfQO>FKBA QEBO>MFPQP CLIILT QEBPB

    J>KR>IP. EB BKBCFQP >OB QE>Q BSFABK@B->PBA QOB>QJBKQ @>K OBAR@B S>OF>FIFQV BQTBBK QEBO>MFPQP QL BKPROB

    QE>Q > PMB@FCF@ >MMOL>@E FP ABIFSBOBA TFQE FKQBDOFQV (#E>OJ>K & >OHE>J, 2005). EBOBCLOB, @IFBKQP E>SB >

    EFDEBO @E>K@B LC OB@BFSFKD QEBO>MBRQF@ FKQBOSBKQFLKP QE>Q >OB BCCB@QFSB >Q QOB>QFKD QEBFO PMB@FCF@ AFPLOABO. EFIB

    FP >PBA LK O>KALJFWBA @LKQOLI QOF>IP, @OFQF@P LC OBGB@Q FQ PQ>QFKD QE>Q QEB OBPRIQP LC QOF>IP @>KKLQ

    B >MMIFBA QL FKAFSFAR>IP >KA FKPQB>A ABQBOJFK>QFLKP OBD>OAFKD QOB>QJBKQ PELRIA B >PBA LK > QEBO>MFPQhP

     GRADJBKQ (RIIBK & QOBFKBO, 2004).

    16.3 Treatment Modalities

    Learning Objectives

    V QEB BKA LC QEFP PB@QFLK, VLR TFII B >IB QL:k   FPQFKDRFPE BQTBBK QEB S>OFLRP JLA>IFQFBP LC QOB>QJBKQk   FP@RPP BKBCFQP LC DOLRM QEBO>MV

    K@B > MBOPLK PBBHP QOB>QJBKQ, TEBQEBO SLIRKQ>OFIV LO FKSLIRKQ>OFIV, EB E>P >K  intake ALKB QL >PPBPPEFP @IFKF@>I KBBAP. K FKQ>HB FP QEB QEBO>MFPQsP CFOPQ JBBQFKD TFQE QEB @IFBKQ. EB QEBO>MFPQ D>QEBOP PMB@FCF@FKCLOJ>QFLK QL >AAOBPP QEB @IFBKQsP FJJBAF>QB KBBAP, PR@E >P QEB MOBPBKQFKD MOLIBJ, QEB @IFBKQsP PRMMLOQ

    PVPQBJ, >KA FKPRO>K@B PQ>QRP. EB QEBO>MFPQ FKCLOJP QEB @IFBKQ >LRQ @LKCFABKQF>IFQV, CBBP, >KA TE>Q QLBUMB@Q FK QOB>QJBKQ.  Confidentiality  JB>KP QEB QEBO>MFPQ @>KKLQ AFP@ILPB @LKCFABKQF>I @LJJRKF@>QFLKPQL >KV QEFOA M>OQV RKIBPP J>KA>QBA LO MBOJFQQBA V I>T QL AL PL. ROFKD QEB FKQ>HB, QEB QEBO>MFPQ >KA@IFBKQ TFII TLOH QLDBQEBO QL AFP@RPP QOB>QJBKQ DL>IP. EBK > QOB>QJBKQ MI>K TFII B CLOJRI>QBA, RPR>IIVTFQE PMB@FCF@ JB>PRO>IB LGB@QFSBP. IPL, QEB QEBO>MFPQ >KA @IFBKQ TFII AFP@RPP ELT QOB>QJBKQ PR@@BPP TFII B JB>PROBA >KA QEB BPQFJ>QBA IBKDQE LC QOB>QJBKQ. EBOB >OB PBSBO>I AFCCBOBKQ JLA>IFQFBP LC QOB>QJBKQ(Figure 16.14): KAFSFAR>I QEBO>MV, C>JFIV QEBO>MV, @LRMIBP QEBO>MV, >KA DOLRM QEBO>MV >OB QEB JLPQ@LJJLK.

    Figure 16.14 EBO>MV J>V L@@RO (>) LKB-LK-LKB BQTBBK > QEBO>MFPQ >KA @IFBKQ, LO () FK > DOLRM PBQQFKD. (@OBAFQ >:

    JLAFCF@>QFLK LC TLOH V #LKKLO !PEIBFDE, !RP!/BM>OQJBKQ LC LOBFDK !CC>FOP >KA O>AB)

    628 #E>MQBO 16 EBO>MV >KA OB>QJBKQ

    EFP @LKQBKQ FP >S>FI>IB CLO COBB >Q https://cnx.org/content/col11629/1.5

  • 8/20/2019 Terapia y Tratamiento

    21/134

    INDIVIDUAL THERAPY

    K individual therapy, >IPL HKLTK >P FKAFSFAR>I MPV@ELQEBO>MV LO FKAFSFAR>I @LRKPBIFKD, QEB @IFBKQ >KA@IFKF@F>K JBBQ LKB-LK-LKB (RPR>IIV COLJ 45 JFKRQBP QL 1 ELRO). EBPB JBBQFKDP QVMF@>IIV L@@RO TBBHIV LOBSBOV LQEBO TBBH, >KA PBPPFLKP >OB @LKAR@QBA FK > @LKCFABKQF>I >KA @>OFKD BKSFOLKJBKQ (Figure 16.15).EB @IFKF@F>K TFII TLOH TFQE @IFBKQP QL EBIM QEBJ BUMILOB QEBFO CBBIFKDP, TLOH QEOLRDE IFCB @E>IIBKDBP,FABKQFCV >PMB@QP LC QEBJPBISBP >KA QEBFO IFSBP QE>Q QEBV TFPE QL @E>KDB, >KA PBQ DL>IP QL EBIM QEBJ TLOH

    QLT>OAP QEBPB @E>KDBP. @IFBKQ JFDEQ PBB > @IFKF@F>K CLO LKIV > CBT PBPPFLKP, LO QEB @IFBKQ J>V >QQBKAFKAFSFAR>I QEBO>MV PBPPFLKP CLO > VB>O LO ILKDBO. EB >JLRKQ LC QFJB PMBKQ FK QEBO>MV ABMBKAP LK QEB KBBAPLC QEB @IFBKQ >P TBII >P EBO MBOPLK>I DL>IP.

    Figure 16.15 K >K FKAFSFAR>I QEBO>MV PBPPFLK, > @IFBKQ TLOHP LKB-LK-LKB TFQE > QO>FKBA QEBO>MFPQ. (@OBAFQ: !I>K

    #IB>SBO)

    GROUP THERAPY

    K group therapy, > @IFKF@F>K JBBQP QLDBQEBO TFQE PBSBO>I @IFBKQP TFQE PFJFI>O MOLIBJP (Figure 16.16).EBK @EFIAOBK >OB MI>@BA FK DOLRM QEBO>MV, FQ FP M>OQF@RI>OIV FJMLOQ>KQ QL J>Q@E @IFBKQP CLO >DB >KAMOLIBJP. KB BKBCFQ LC DOLRM QEBO>MV FP QE>Q FQ @>K EBIM AB@OB>PB > @IFBKQs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

    DRFIQV >KA JLOB PRMMLOQBA V BFKD FK > DOLRM TFQE PFJFI>O TLJBK.OLRM QEBO>MV >IPL E>P PLJB PMB@FCF@ IFJFQ>QFLKP. BJBOP LC QEB DOLRM J>V B >CO>FA QL PMB>H FKCOLKQ LC LQEBO MBLMIB B@>RPB PE>OFKD PB@OBQP >KA MOLIBJP TFQE @LJMIBQB PQO>KDBOP @>K B PQOBPPCRI >KALSBOTEBIJFKD. EBOB J>V B MBOPLK>IFQV @I>PEBP >KA >ODRJBKQP >JLKD DOLRM JBJBOP. EBOB @LRIA >IPL B @LK@BOKP >LRQ @LKCFABKQF>IFQV: LJBLKB COLJ QEB DOLRM JFDEQ PE>OB TE>Q >KLQEBO M>OQF@FM>KQ P>FA QLMBLMIB LRQPFAB LC QEB DOLRM.

    #E>MQBO 16 EBO>MV >KA OB>QJBKQ 629

  • 8/20/2019 Terapia y Tratamiento

    22/134

    Figure 16.16 K DOLRM QEBO>MV, RPR>IIV 5e10 MBLMIB JBBQ TFQE > QO>FKBA QEBO>MFPQ QL AFP@RPP > @LJJLK FPPRB PR@E

    >P AFSLO@B, DOFBC, >K B>QFKD AFPLOABO, PRPQ>K@B >RPB, LO >KDBO J>K>DBJBKQ. (@OBAFQ: #LOV >KHBO)

    KLQEBO BKBCFQ LC DOLRM QEBO>MV FP QE>Q JBJBOP @>K @LKCOLKQ B>@E LQEBO >LRQ QEBFO M>QQBOKP. LO QELPBTFQE PLJB QVMBP LC MOLIBJP, PR@E >P PBUR>I >RPBOP, DOLRM QEBO>MV FP QEB OB@LJJBKABA QOB>QJBKQ. OLRM

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

    OLRMP QE>Q E>SB > PQOLKD BAR@>QFLK>I @LJMLKBKQ >OB @>IIBA MPV@EL-BAR@>QFLK>I DOLRMP. LO BU>JMIB, >DOLRM CLO @EFIAOBK TELPB M>OBKQP E>SB @>K@BO JFDEQ AFP@RPP FK ABMQE TE>Q @>K@BO FP, QVMBP LC QOB>QJBKQCLO @>K@BO, >KA QEB PFAB BCCB@QP LC QOB>QJBKQP, PR@E >P E>FO ILPP. CQBK, DOLRM QEBO>MV PBPPFLKP TFQE @EFIAOBKQ>HB MI>@B FK P@ELLI. EBV >OB IBA V > P@ELLI @LRKPBILO, > P@ELLI MPV@ELILDFPQ, LO > P@ELLI PL@F>I TLOHBO.OLRMP JFDEQ CL@RP LK QBPQ >KUFBQV, PL@F>I FPLI>QFLK, PBIC-BPQBBJ, RIIVFKD, LO P@ELLI C>FIROB (EB@EQJ>K,

    2002). EBQEBO QEB DOLRM FP EBIA FK P@ELLI LO FK > @IFKF@F>KsP LCCF@B, DOLRM QEBO>MV E>P BBK CLRKA QL BBCCB@QFSB TFQE @EFIAOBK C>@FKD KRJBOLRP HFKAP LC @E>IIBKDBP (EB@EQJ>K, 2002).

    ROFKD > DOLRM PBPPFLK, QEB BKQFOB DOLRM @LRIA OBCIB@Q LK >K FKAFSFAR>Is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

    COUPLES THERAPY

    Couples therapy FKSLISBP QTL MBLMIB FK >K FKQFJ>QB OBI>QFLKPEFM TEL >OB E>SFKD AFCCF@RIQFBP >KA >OB QOVFKDQL OBPLISB QEBJ (Figure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

    630 #E>MQBO 16 EBO>MV >KA OB>QJBKQ

    EFP @LKQBKQ FP >S>FI>IB CLO COBB >Q https://cnx.org/content/col11629/1.5

  • 8/20/2019 Terapia y Tratamiento

    23/134

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s QEBO>MV QL B IFHB pMFILQFKD > EBIF@LMQBO FK > EROOF@>KBq (BFI, 2012,M>O>. 7).

    Figure 16.17 K @LRMIBP @LRKPBIFKD, > QEBO>MFPQ EBIMP MBLMIB TLOH LK QEBFO OBI>QFLKPEFM. (@OBAFQ: #LOV >KHBO)

    FAMILY THERAPY

    Family therapy FP > PMB@F>I CLOJ LC DOLRM QEBO>MV, @LKPFPQFKD LC LKB LO JLOB C>JFIFBP. IQELRDE QEBOB >OBJ>KV QEBLOBQF@>I LOFBKQ>QFLKP FK C>JFIV QEBO>MV, LKB LC QEB JLPQ MOBALJFK>KQ FP QEB PVPQBJP >MMOL>@E.

    EB C>JFIV FP SFBTBA >P >K LOD>KFWBA PVPQBJ, >KA B>@E FKAFSFAR>I TFQEFK QEB C>JFIV FP > @LKQOFRQFKDJBJBO TEL @OB>QBP >KA J>FKQ>FKP MOL@BPPBP TFQEFK QEB PVPQBJ QE>Q PE>MB BE>SFLO (FKR@EFK, 1985).>@E JBJBO LC QEB C>JFIV FKCIRBK@BP >KA FP FKCIRBK@BA V QEB LQEBOP. EB DL>I LC QEFP >MMOL>@E FP QLBKE>K@B QEB DOLTQE LC B>@E C>JFIV JBJBO >P TBII >P QE>Q LC QEB C>JFIV >P > TELIB.

    CQBK, AVPCRK@QFLK>I M>QQBOKP LC @LJJRKF@>QFLK QE>Q ABSBILM BQTBBK C>JFIV JBJBOP @>K IB>A QL @LKCIF@Q. C>JFIV TFQE QEFP AVK>JF@ JFDEQ TFPE QL >QQBKA QEBO>MV QLDBQEBO O>QEBO QE>K FKAFSFAR>IIV. K J>KV@>PBP, LKB JBJBO LC QEB C>JFIV E>P MOLIBJP QE>Q ABQOFJBKQ>IIV >CCB@Q BSBOVLKB. LO BU>JMIB, > JLQEBOsPABMOBPPFLK, QBBK A>RDEQBOsP B>QFKD AFPLOABO, LO C>QEBOsP >I@LELI ABMBKABK@B @LRIA >CCB@Q >II JBJBOP LC QEBC>JFIV. EB QEBO>MFPQ TLRIA TLOH TFQE >II JBJBOP LC QEB C>JFIV QL EBIM QEBJ @LMB TFQE QEB FPPRB, >KA QLBK@LRO>DB OBPLIRQFLK >KA DOLTQE FK QEB @>PB LC QEB FKAFSFAR>I C>JFIV JBJBO TFQE QEB MOLIBJ.

    FQE C>JFIV QEBO>MV, QEB KR@IB>O C>JFIV (F.B., M>OBKQP >KA @EFIAOBK) LO QEB KR@IB>O C>JFIV MIRP TELBSBO IFSBP

    FK QEB ELRPBELIA (B.D., DO>KAM>OBKQ) @LJB FKQL QOB>QJBKQ. >JFIV QEBO>MFPQP TLOH TFQE QEB TELIB C>JFIVRKFQ QL EB>I QEB C>JFIV. EBOB >OB PBSBO>I AFCCBOBKQ QVMBP LC C>JFIV QEBO>MV. K structural family therapy,QEB QEBO>MFPQ BU>JFKBP >KA AFP@RPPBP QEB LRKA>OFBP >KA PQOR@QROB LC QEB C>JFIV: TEL J>HBP QEB ORIBP, TELPIBBMP FK QEB BA TFQE TELJ, ELT AB@FPFLKP >OB J>AB, >KA TE>Q >OB QEB LRKA>OFBP TFQEFK QEB C>JFIV. KPLJB C>JFIFBP, QEB M>OBKQP AL KLQ TLOH QLDBQEBO QL J>HB ORIBP, LO LKB M>OBKQ J>V RKABOJFKB QEB LQEBO,IB>AFKD QEB @EFIAOBK QL >@Q LRQ. EB QEBO>MFPQ EBIMP QEBJ OBPLISB QEBPB FPPRBP >KA IB>OK QL @LJJRKF@>QBJLOB BCCB@QFSBIV.

    #E>MQBO 16 EBO>MV >KA OB>QJBKQ 631

  • 8/20/2019 Terapia y Tratamiento

    24/134

    >Q@E QEFP video (http://openstaxcollege.org/l/Sfamily) QL SFBT > PQOR@QRO>I C>JFIV

    PBPPFLK.

    K strategic family therapy, QEB DL>I FP QL >AAOBPP PMB@FCF@ MOLIBJP TFQEFK QEB C>JFIV QE>Q @>K B AB>IQ TFQEFK > OBI>QFSBIV PELOQ >JLRKQ LC QFJB. VMF@>IIV, QEB QEBO>MFPQ TLRIA DRFAB TE>Q E>MMBKP FK QEB QEBO>MVPBPPFLK >KA ABPFDK > ABQ>FIBA >MMOL>@E QL OBPLISFKD B>@E JBJBOsP MOLIBJ (>A>KBP, 1991).

    16.4 Substance-Related and Addictive Disorders: A Special Case

    Learning Objectives

    V QEB BKA LC QEFP PB@QFLK, VLR TFII B >IB QL:k   B@LDKFWB QEB DL>I LC PRPQ>K@B-OBI>QBA >KA >AAF@QFSB AFPLOABOP QOB>QJBKQ

    k   FP@RPP TE>Q J>HBP CLO BCCB@QFSB QOB>QJBKQk   BP@OFB ELT @LJLOFA AFPLOABOP >OB QOB>QBA

    AAF@QFLK FP LCQBK SFBTBA >P > @EOLKF@ AFPB>PB (Figure 16.18). EB @ELF@B QL RPB > PRPQ>K@B FP FKFQF>IIVSLIRKQ>OV; ELTBSBO, B@>RPB @EOLKF@ PRPQ>K@B RPB @>K MBOJ>KBKQIV >IQBO QEB KBRO>I PQOR@QROB FK QEBMOBCOLKQ>I @LOQBU, >K >OB> LC QEB O>FK >PPL@F>QBA TFQE AB@FPFLK-J>HFKD >KA GRADJBKQ, > MBOPLK B@LJBPAOFSBK QL RPB AORDP >KA/LO >I@LELI (RgLW-RBS>P, QEFIFKD>J, FP@LML, & FIOB@EQ, 2013). EFP EBIMPBUMI>FK TEV OBI>MPB O>QBP QBKA QL B EFDE. LRQ 40%n60% LC FKAFSFAR>IP relapse, TEF@E JB>KP QEBV OBQROKQL >RPFKD AORDP >KA/LO >I@LELI >CQBO > MBOFLA LC FJMOLSBJBKQ (>QFLK>I KPQFQRQB LK ORD RPB MQBO 16 EBO>MV >KA OB>QJBKQ

    EFP @LKQBKQ FP >S>FI>IB CLO COBB >Q https://cnx.org/content/col11629/1.5

    http://openstaxcollege.org/l/Sfamilyhttp://openstaxcollege.org/l/Sfamily

  • 8/20/2019 Terapia y Tratamiento

    25/134

    Figure 16.18 EB >QFLK>I ROSBV LK ORD PB >KA B>IQE PELTP QOBKAP FK MOBS>IBK@B LC S>OFLRP AORDP CLO >DBP

    12e17, 18e25, >KA 26 LO LIABO.

    EB DL>I LC PRPQ>K@B-OBI>QBA QOB>QJBKQ FP QL EBIM >K >AAF@QBA MBOPLK PQLM @LJMRIPFSB AORD-PBBHFKD BE>SFLOP (, 2012). EFP JB>KP >K >AAF@QBA MBOPLK TFII KBBA ILKD-QBOJ QOB>QJBKQ, PFJFI>O QL > MBOPLK >QQIFKD > @EOLKF@ MEVPF@>I AFPB>PB PR@E >P EVMBOQBKPFLK LO AF>BQBP. OB>QJBKQ RPR>IIV FK@IRABP BE>SFLO>IQEBO>MV >KA/LO JBAF@>QFLK, ABMBKAFKD LK QEB FKAFSFAR>I (, 2012). MB@F>IFWBA QEBO>MFBP E>SB >IPL BBK ABSBILMBA CLO PMB@FCF@ QVMBP LC PRPQ>K@B-OBI>QBA AFPLOABOP, FK@IRAFKD >I@LELI, @L@>FKB, >KA LMFLFAP(@LSBOK & >OOLII, 2003). RPQ>K@B-OBI>QBA QOB>QJBKQ FP @LKPFABOBA JR@E JLOB @LPQ-BCCB@QFSB QE>KFK@>O@BO>QFLK LO KLQ QOB>QFKD QELPB TFQE >AAF@QFLKP (, 2012) (Figure 16.19).

    Figure 16.19 RPQ>K@B RPB >KA >RPB @LPQP QEB KFQBA Q>QBP LSBO $600 FIIFLK > VB>O (!, 2012). EFP >AAF@Q FP

    RPFKD EBOLFK. (@OBAFQ: "GBIIVJ@ - RO>KPK>MP"/IF@HO)

    #E>MQBO 16 EBO>MV >KA OB>QJBKQ 633

  • 8/20/2019 Terapia y Tratamiento

    26/134

    WHAT MAKES TREATMENT EFFECTIVE?

    MB@FCF@ C>@QLOP J>HB PRPQ>K@B-OBI>QBA QOB>QJBKQ JR@E JLOB BCCB@QFSB. KB C>@QLO FP ARO>QFLK LC QOB>QJBKQ.BKBO>IIV, QEB >AAF@Q KBBAP QL B FK QOB>QJBKQ CLO >Q IB>PQ QEOBB JLKQEP QL >@EFBSB > MLPFQFSB LRQ@LJB(FJMPLK, 1981; FJMPLK, *LB, & O>@V, 1982; , 2012). EFP FP ARB QL QEB MPV@ELILDF@>I, MEVPFLILDF@>I, BE>SFLO>I, >KA PL@F>I >PMB@QP LC >RPB (FJMPLK, 1981; FJMPLK BQ >I., 1982; , 2012). EFIB FKQOB>QJBKQ, >K >AAF@Q JFDEQ OB@BFSB BE>SFLO QEBO>MV, TEF@E @>K EBIM JLQFS>QB QEB >AAF@Q QL M>OQF@FM>QB FK

    QEB QOB>QJBKQ MOLDO>J >KA QB>@E PQO>QBDFBP CLO AB>IFKD TFQE @O>SFKDP >KA ELT QL MOBSBKQ OBI>MPB. IPL,QOB>QJBKQ KBBAP QL B ELIFPQF@ >KA >AAOBPP JRIQFMIB KBBAP, KLQ GRPQ QEB AORD >AAF@QFLK. EFP JB>KP QE>QQOB>QJBKQ TFII >AAOBPP C>@QLOP PR@E >P @LJJRKF@>QFLK, PQOBPP J>K>DBJBKQ, OBI>QFLKPEFM FPPRBP, M>OBKQFKD,SL@>QFLK>I @LK@BOKP, >KA IBD>I @LK@BOKP (@LSBOK & >OOLII, 2003; , 2012).

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

     V QBBK PRPQ>K@B >RPBOP. IPL, JLQEBOP TEL M>OQF@FM>QBA FK QOB>QJBKQ AFPMI>VBA BQQBO JBKQ>I EB>IQE>KA DOB>QBO T>OJQE QLT>OA QEBFO @EFIAOBK (BOQO>KA BQ >I., 2013). LTBSBO, KBFQEBO FKAFSFAR>I KLO DOLRMQEBO>MV E>P BBK CLRKA QL B JLOB BCCB@QFSB (BFPP BQ >I., 2004). BD>OAIBPP LC QEB QVMB LC QOB>QJBKQ PBOSF@B,QEB MOFJ>OV CL@RP FP LK >PQFKBK@B LO >Q QEB SBOV IB>PQ > PFDKFCF@>KQ OBAR@QFLK FK RPB (@LSBOK & >OOLII,2003).

    OB>QJBKQ >IPL RPR>IIV FKSLISBP JBAF@>QFLKP QL ABQLU QEB >AAF@Q P>CBIV >CQBO >K LSBOALPB, QL MOBSBKQPBFWROBP >KA >DFQ>QFLK QE>Q LCQBK L@@RO FK ABQLU, QL MOBSBKQ OBRPB LC QEB AORD, >KA QL J>K>DB TFQEAO>T>IPVJMQLJP. BQQFKD LCC AORDP LCQBK FKSLISBP QEB RPB LC AORDPoPLJB LC TEF@E @>K B GRPQ >P >[email protected] @>K B AFCCF@RIQ >KA A>KDBOLRP.

    >Q@E QEFP video (http://openstaxcollege.org/l/subdisorder) QL CFKA LRQ JLOB >LRQ

    QOB>QFKD PRPQ>K@B-OBI>QBA AFPLOABOP RPFKD QEB FLILDF@>I, BE>SFLO>I, >KA

    MPV@ELAVK>JF@ >MMOL>@EBP.

    COMORBID DISORDERS

    OBNRBKQIV, > MBOPLK TEL FP >AAF@QBA QL AORDP >KA/LO >I@LELI E>P >K >AAFQFLK>I MPV@ELILDF@>I AFPLOABO.>VFKD > MBOPLK E>P   comorbid disorders  JB>KP QEB FKAFSFAR>I E>P QTL LO JLOB AF>DKLPBP. EFP @>K

    LCQBK B > PRPQ>K@B-OBI>QBA AF>DKLPFP >KA >KLQEBO MPV@EF>QOF@ AF>DKLPFP, PR@E >P ABMOBPPFLK, FMLI>OAFPLOABO, LO P@EFWLMEOBKF>. EBPB FKAFSFAR>IP C>II FKQL QEB @>QBDLOV LC JBKQ>IIV FII >KA @EBJF@>IIV >AAF@QBA()oQEBFO MOLIBJP >OB LCQBK @EOLKF@ >KA BUMBKPFSB QL QOB>Q, TFQE IFJFQBA PR@@BPP. LJM>OBA TFQE QEBLSBO>II MLMRI>QFLK, PRPQ>K@B >RPBOP >OB QTF@B >P IFHBIV QL E>SB > JLLA LO >KUFBQV AFPLOABO. ORD >RPB@>K @>RPB PVJMQLJP LC JLLA >KA >KUFBQV AFPLOABOP >KA QEB OBSBOPB FP >IPL QORBoMBLMIB TFQE ABFIFQ>QFKDPVJMQLJP LC > MPV@EF>QOF@ AFPLOABO J>V PBIC-JBAF@>QB >KA >RPB PRPQ>K@BP.

    K @>PBP LC @LJLOFAFQV, QEB BPQ QOB>QJBKQ FP QELRDEQ QL >AAOBPP LQE (LO JRIQFMIB) AFPLOABOPPFJRIQ>KBLRPIV (, 2012). BE>SFLO QEBO>MFBP >OB RPBA QL QOB>Q @LJLOFA @LKAFQFLKP, >KA FK J>KV@>PBP, MPV@ELQOLMF@ JBAF@>QFLKP >OB RPBA >ILKD TFQE MPV@ELQEBO>MV. LO BU>JMIB, BSFABK@B PRDDBPQP

    LINK TO LEARNING

    634 #E>MQBO 16 EBO>MV >KA OB>QJBKQ

    EFP @LKQBKQ FP >S>FI>IB CLO COBB >Q https://cnx.org/content/col11629/1.5

    http://openstaxcollege.org/l/subdisorderhttp://openstaxcollege.org/l/subdisorder

  • 8/20/2019 Terapia y Tratamiento

    27/134

    QE>Q RMOLMFLK (QO>AB K>JBP: BIIRQOFK >KA V>K), >MMOLSBA CLO QOB>QFKD ABMOBPPFLK >KA KF@LQFKBABMBKABK@B, JFDEQ >IPL EBIM OBAR@B @O>SFKD >KA RPB LC QEB AORD JBQE>JMEBQ>JFKB (, 2011).LTBSBO, JLOB OBPB>O@E FP KBBABA QL BQQBO RKABOPQ>KA ELT QEBPB JBAF@>QFLKP TLOHoM>OQF@RI>OIV TEBK@LJFKBA FK M>QFBKQP TFQE @LJLOFAFQFBP.

    16.5 The Sociocultural Model and Therapy Utilization

    Learning Objectives

    V QEB BKA LC QEFP PB@QFLK, VLR TFII B >IB QL:k   UMI>FK ELT QEB PL@FL@RIQRO>I JLABI FP RPBA FK QEBO>MVk   FP@RPP >OOFBOP QL JBKQ>I EB>IQE PBOSF@BP >JLKD BQEKF@ JFKLOFQFBP

    EB PL@FL@RIQRO>I MBOPMB@QFSB ILLHP >Q VLR, VLRO BE>SFLOP, >KA VLRO PVJMQLJP FK QEB @LKQBUQ LC VLRO@RIQROB >KA >@HDOLRKA. LO BU>JMIB, *LPb FP >K 18-VB>O-LIA FPM>KF@ J>IB COLJ > QO>AFQFLK>I C>JFIV. *LPb @LJBP QL QOB>QJBKQ B@>RPB LC ABMOBPPFLK. ROFKD QEB FKQ>HB PBPPFLK, EB OBSB>IP QE>Q EB FP D>V >KA FPKBOSLRP >LRQ QBIIFKD EFP C>JFIV. B >IPL AFP@ILPBP QE>Q EB FP @LK@BOKBA B@>RPB EFP OBIFDFLRP >@HDOLRKA

    E>P Q>RDEQ EFJ QE>Q ELJLPBUR>IFQV FP TOLKD. LT ALBP EFP OBIFDFLRP >KA @RIQRO>I >@HDOLRKA >CCB@Q EFJ?LT JFDEQ EFP @RIQRO>I >@HDOLRKA >CCB@Q ELT EFP C>JFIV OB>@QP FC *LPb TBOB QL QBII QEBJ EB FP D>V?

    P LRO PL@FBQV B@LJBP FK@OB>PFKDIV JRIQFBQEKF@ >KA JRIQFO>@F>I, JBKQ>I EB>IQE MOLCBPPFLK>IP JRPQABSBILM cultural competence (Figure 16.20), TEF@E JB>KP QEBV JRPQ RKABOPQ>KA >KA >AAOBPP FPPRBP LC O>@B, @RIQROB, >KA BQEKF@FQV. EBV JRPQ >IPL ABSBILM PQO>QBDFBP QL BCCB@QFSBIV >AAOBPP QEB KBBAP LC S>OFLRPMLMRI>QFLKP CLO TEF@E ROL@BKQOF@ QEBO>MFBP E>SB IFJFQBA >MMIF@>QFLK (RB, 2004). LO BU>JMIB, > @LRKPBILOTELPB QOB>QJBKQ CL@RPBP LK FKAFSFAR>I AB@FPFLK J>HFKD J>V B FKBCCB@QFSB >Q EBIMFKD > EFKBPB @IFBKQ TFQE> @LIIB@QFSFPQ >MMOL>@E QL MOLIBJ PLISFKD (RB, 2004).

    RIQF@RIQRO>I @LRKPBIFKD >KA QEBO>MV >FJP QL LCCBO LQE > EBIMFKD OLIB >KA MOL@BPP QE>Q RPBP JLA>IFQFBP>KA ABCFKBP DL>IP @LKPFPQBKQ TFQE QEB IFCB BUMBOFBK@BP >KA @RIQRO>I S>IRBP LC @IFBKQP. Q PQOFSBP QL OB@LDKFWB@IFBKQ FABKQFQFBP QL FK@IRAB FKAFSFAR>I, DOLRM, >KA RKFSBOP>I AFJBKPFLKP, >ASL@>QB QEB RPB LC RKFSBOP>I >KA

    @RIQROB-PMB@FCF@ PQO>QBDFBP >KA OLIBP FK QEB EB>IFKD MOL@BPP, >KA >I>K@P QEB FJMLOQ>K@B LC FKAFSFAR>IFPJ>KA @LIIB@QFSFPJ FK QEB >PPBPPJBKQ, AF>DKLPFP, >KA QOB>QJBKQ LC @IFBKQ >KA @IFBKQ PVPQBJP (RB, 2001).

    EFP QEBO>MBRQF@ MBOPMB@QFSB FKQBDO>QBP QEB FJM>@Q LC @RIQRO>I >KA PL@F>I KLOJP, PQ>OQFKD >Q QEB BDFKKFKDLC QOB>QJBKQ. EBO>MFPQP TEL RPB QEFP MBOPMB@QFSB TLOH TFQE @IFBKQP QL LQ>FK >KA FKQBDO>QB FKCLOJ>QFLK>LRQ QEBFO @RIQRO>I M>QQBOKP FKQL > RKFNRB QOB>QJBKQ >MMOL>@E >PBA LK QEBFO M>OQF@RI>O PFQR>QFLK (QBT>OQ,FJJLKP, & >FMLRO, 2012). L@FL@RIQRO>I QEBO>MV @>K FK@IRAB FKAFSFAR>I, DOLRM, C>JFIV, >KA @LRMIBPQOB>QJBKQ JLA>IFQFBP.

    #E>MQBO 16 EBO>MV >KA OB>QJBKQ 635

  • 8/20/2019 Terapia y Tratamiento

    28/134

    Figure 16.20 LT AL VLRO @RIQRO>I >KA OBIFDFLRP BIFBCP >CCB@Q VLRO >QQFQRAB QLT>OA JBKQ>I EB>IQE QOB>QJBKQ? (@OBAFQ

    iQLM-IBCQj: JLAFCF@>QFLK LC TLOH V Q>CC>K @EBOW; @OBAFQ iQLM-IBCQ-JFAAIBj: JLAFCF@>QFLK LC TLOH V !IBG>KAO> RFKQBOL

    FKFPQBOO>; @OBAFQ iQLM-OFDEQ-JFAAIBj: JLAFCF@>QFLK LC TLOH V BAOL FBFOL FJ`BP; @OBAFQ iQLM-OFDEQj: JLAFCF@>QFLK LC

     TLOH